Please sign in to follow a disease.
Bacterial infectious disease
MONDO:0005113An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.
Also known as: Bacteria caused disease or disorder, Bacteria disease or disorder, Bacteria infectious disease, bacterial disease, bacterial disorder, bacterial infection, bacterial infectious disease, infection, bacterial
1771 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 569 trials in this tab.
-
New single-dose pill may beat week-long treatment for common STI
⭐️ CURE ⭐️ Recruiting nowThis study compares two oral treatments for trichomonas, a common sexually transmitted infection. About 1,200 women and men with a positive test will receive either a single dose of secnidazole or multiple doses of metronidazole over several days. The goal is to see which approac…
Phase: PHASE4 • Sponsor: Tulane University • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New pneumonia vaccine candidate enters early human safety testing
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study is testing a new vaccine called V118E to see if it is safe and well-tolerated in healthy adults. The vaccine aims to protect against infections caused by Streptococcus pneumoniae bacteria, which can cause pneumonia and other serious illnesses. Around 126 he…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 01, 2026 00:00 UTC
-
New vaccine aims to shield kids from pneumonia and meningitis
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new pneumococcal vaccine (PG4) in healthy children aged 15 months to 18 years. About 1,200 participants will receive either the new vaccine or the current Prevnar 20. Researchers will compare safety and immune response over 6 months. The goal is to see if the n…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
New vaccine could shield babies from deadly infection before birth
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a vaccine given to pregnant women to see if it can protect their babies from group B streptococcus (GBS) infection, a serious illness in newborns. Healthy pregnant women aged 49 or younger, between 24 and 36 weeks of pregnancy, can join. Participants receive one …
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
New plague vaccine enters human testing
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine called rF1V-1018 to prevent pneumonic plague, a severe lung infection spread by aerosol. Researchers will give the vaccine to 148 healthy adults aged 18 to 55 to check if it triggers a strong immune response and is safe. The goal is to find the best…
Phase: PHASE2 • Sponsor: Dynavax Technologies Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:00 UTC
-
New vaccine targets group a strep in first human test
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a new vaccine called VAX-A1 in 80 healthy adults aged 18-40. The vaccine aims to prevent infections caused by Group A Streptococcus bacteria, which can cause strep throat and more serious illnesses. The study focuses on safety and immune response, wit…
Phase: PHASE1 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:00 UTC
-
New vaccine aims to shield babies from pneumonia and meningitis
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new pneumococcal vaccine in healthy infants to see if it is safe and works better than the current vaccine. About 3,230 babies will receive either the new vaccine or the existing one at routine checkups. Researchers will compare side effects and immune response…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:03 UTC
-
New mRNA vaccine could stop lyme disease in its tracks
⭐️ VACCINE ⭐️ Recruiting nowThis study tests an experimental mRNA vaccine (mRNA-1982) designed to prevent Lyme disease, which is spread by tick bites. About 350 healthy adults aged 18 to 70 will receive either the vaccine or a placebo to check for safety and immune response. The goal is to find the best dos…
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:39 UTC
-
New infant vaccine trial aims to shield against pneumonia and meningitis
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new pneumococcal vaccine in about 2400 healthy infants starting at 2 months old. The goal is to see if the new vaccine is as safe as the current vaccine, Prevnar 20, and if it can protect against more types of bacteria that cause pneumonia, meningitis, and ear …
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:38 UTC
-
Pfizer launches massive trial of c. diff vaccine for seniors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether a vaccine can prevent C. difficile infection in adults 65 and older. About 32,000 participants will receive either the vaccine or a placebo shot. The study will track infections and side effects over up to three and a half years.
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:37 UTC
-
Pfizer gives lyme vaccine a fifth dose — will it boost protection?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether a fifth dose of Pfizer's Lyme disease vaccine (VLA15) is safe and boosts immunity in people who already received four doses. About 1,700 healthy volunteers aged 7 and older will get either the vaccine or a saltwater shot. Researchers will compare side eff…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New vaccine study targets sneaky pneumonia bacteria
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether two different pneumococcal vaccines can create antibodies that kill newly discovered types of pneumonia bacteria. Researchers will give healthy adults one of the vaccines and measure how well their immune system fights these bacteria. The goal is to see i…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New e. coli vaccine enters first human safety trial
⭐️ VACCINE ⭐️ Recruiting nowPfizer is testing several experimental vaccines designed to protect against E. coli bacteria. This early-stage study involves 310 healthy adults aged 18 to 64. The main goal is to check if the vaccines are safe and tolerable, not yet whether they work. Participants will receive t…
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:26 UTC
-
Could a vaccine stop recurrent UTIs? new trial underway
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine designed to prevent urinary tract infections (UTIs) caused by E. coli bacteria. Researchers will check safety and immune response in 448 adults aged 18-64, and then see if it works in women of the same age. Participants receive either the vaccine or…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New vaccine aims to shield african infants from two deadly infections
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new vaccine called iNTS-TCV in 537 infants in Africa. The vaccine is designed to protect against two serious bacterial infections: invasive nontyphoidal salmonella (iNTS) and typhoid fever. Researchers are giving the vaccine to infants starting at either 6…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:10 UTC
-
New vaccine V118C aims to shield kids from pneumococcal disease
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial is testing a new vaccine called V118C to prevent pneumococcal disease, which can cause serious lung and other infections. About 210 toddlers and infants will receive either V118C or an existing vaccine to compare safety and immune response. The study is cur…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:08 UTC
-
New vaccine aims to shield sickle cell kids from deadly infections
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new 21-valent pneumococcal vaccine (PCV21) in 100 children and teens with sickle cell disease, aged 2 to 17. The goal is to see if it's safe and helps the body make antibodies better than the current 20-valent vaccine. Participants get one shot and are monitore…
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:08 UTC
-
Can a vaccine series shield CLL patients from pneumonia?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether a two-shot pneumonia vaccine series (PCV20 and PPSV23) can help people with chronic lymphocytic leukemia (CLL) build a stronger immune defense against pneumococcal infections. About 61 adults with CLL who have not yet had treatment, or who are on a specif…
Phase: PHASE2 • Sponsor: University of Utah • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:06 UTC
-
Could an mRNA vaccine stop chlamydia? new trial begins
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new mRNA vaccine designed to prevent chlamydia, a common sexually transmitted infection. About 1,560 adults aged 18 to 29 who are at higher risk of infection will receive either a low, medium, or high dose of the vaccine or a placebo. Researchers will monitor s…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
New meningitis b vaccine enters human testing
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial is testing a new vaccine called DX-104 to see if it is safe and triggers an immune response against group B meningococcal bacteria, which can cause meningitis. The study involves 30 healthy adults aged 18 to 50 who will receive either the new vaccine or an …
Phase: PHASE1 • Sponsor: Shanghai Yuguan Biotech Co., Ltd.(Delonix Bioworks) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:04 UTC
-
New cholera vaccine trial aims to protect families in High-Risk areas
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new cholera vaccine (OSP:rTTHc CCV) in 390 healthy adults and children aged 1 to 45 in a region where cholera is common. The goal is to see if the vaccine is safe and triggers a strong immune response. Some participants get the vaccine with or without an adjuva…
Phase: PHASE2 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
Could this new vaccine end tuberculosis?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine called MTBVAC to see if it can prevent tuberculosis (TB) disease in teens and adults aged 14 to 45 who live in areas where TB is common. About 5,500 volunteers will receive either the vaccine or a placebo, and researchers will track who develops TB …
Phase: PHASE2 • Sponsor: International AIDS Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
Can you get the pneumonia shot while sick? new study finds out
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at whether giving the 20-valent pneumococcal vaccine (PCV-20) to adults while they have a fever is as effective and safe as waiting until they are well. About 1052 adults with certain health risks (like heart or lung disease) will take part. The goal is to see if…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
Could a Once-a-Year cholera shot be just as good?
⭐️ VACCINE ⭐️ Recruiting nowThis study in Nairobi, Kenya, is testing whether giving the oral cholera vaccine Euvichol-S at longer intervals (3 months or 12 months) works as well as the standard 2-week schedule. Over 1,000 healthy participants aged 1 year and older will be randomly assigned to one of three d…
Phase: PHASE4 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
New TB vaccine candidate MTBVAC enters key safety trial in south africa
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new tuberculosis vaccine called MTBVAC in 276 adolescents and adults in South Africa, some of whom have HIV. The goal is to see if the vaccine is safe and triggers a strong immune response. Participants will receive either MTBVAC or the standard BCG vaccin…
Phase: PHASE2 • Sponsor: HIV Vaccine Trials Network • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
Korean study monitors prevenar 20 vaccine safety
⭐️ VACCINE ⭐️ Recruiting nowThis study is checking how safe the Prevenar 20 vaccine is once it's used in Korea. About 660 people aged 6 weeks and older who are prescribed the vaccine will get one dose. Researchers will track any side effects for 28 days after vaccination.
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
New vaccine aims to shield infants from deadly pneumonia
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine to protect babies against pneumococcal infections, which can cause pneumonia and meningitis. About 600 healthy infants in Thailand will receive either the new or a standard vaccine at 2, 4, and 12-15 months old. Researchers will check how well the v…
Phase: PHASE3 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:09 UTC
-
New pneumonia vaccine trial aims to shield 3,000 kids from deadly infection
⭐️ VACCINE ⭐️ Recruiting nowThis Phase 3 trial is testing a new 13-valent pneumococcal conjugate vaccine (PCV13) in over 3,000 healthy infants and children aged 6 weeks to 5 years. The goal is to see if the vaccine is safe and triggers a strong immune response compared to an existing vaccine. If it works, i…
Phase: PHASE3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New vaccine aims to shield toddlers from 24 pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (PCV24) designed to protect children aged 2 to 23 months against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. Around 180 healthy children will receive either the new vaccine or an existing one …
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThis study tests whether an investigational drug called PLG0206 can prevent infections from coming back after knee replacement surgery. About 240 adults who need a special cleaning surgery (DAIR) for an infected knee joint will receive either PLG0206 or a placebo during the proce…
Phase: PHASE2, PHASE3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Jul 03, 2026 23:00 UTC
-
Could a poop pill help heal after colon surgery?
Disease control Recruiting nowThis early study is testing whether giving a transplant of healthy gut bacteria (called IMT) through a feeding tube is safe and doable in 40 adults who have had part of their colon removed due to diverticulitis or sigmoid colon cancer. Participants get the transplant a couple of …
Phase: PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 03, 2026 23:00 UTC
-
Could vitamin B3 help beat TB? new trial launches
Disease control Recruiting nowThis phase 2 trial tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible pulmonary tuberculosis. About 165 adults with newly diagnosed TB will receive one of two doses of nicotinamide plus the s…
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jul 03, 2026 23:00 UTC
-
Poop pills could protect gut after colon surgery – early trial begins
Disease control Recruiting nowThis early-stage trial is testing whether a pill made from freeze-dried healthy donor stool (MTP-101P) is safe and can restore good bacteria in people having part of their colon removed. Forty adults aged 18-75 with colon polyps, early-stage cancer, or diverticulitis will take th…
Phase: PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 03, 2026 23:00 UTC
-
New hope for kids with tough infections: experimental antibiotic combo tested
Disease control Recruiting nowThis study tests a new IV antibiotic (aztreonam-avibactam) in hospitalized children aged 9 months to 18 years with serious gram-negative bacterial infections. About 48 participants will receive either the new drug or the best available standard treatment. The goal is to see how t…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New eye drop aims to zap pink eye germs
Disease control Recruiting nowThis trial tests a new antibiotic eye drop called SUM-191 for bacterial conjunctivitis (pink eye). It has three parts: first, healthy volunteers get a single dose to check safety; second, healthy volunteers get multiple doses for 6 days; third, patients with pink eye get the drop…
Phase: PHASE1, PHASE2 • Sponsor: Senju USA, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug cocktail could simplify treatment for dangerous lung lining infection
Disease control Recruiting nowThis study tests two different drug combinations for pleural infection, a serious infection of the lung lining that often requires surgery. The standard treatment uses two drugs (alteplase and DNase) given through a chest tube. This trial compares that to a new combination using …
Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New antibiotic pill could heal Flesh-Eating ulcers in weeks
Disease control Recruiting nowThis study tests a new antibiotic called telacebec for Buruli ulcer, a bacterial skin infection that can cause large open sores. About 200 adults will take telacebec tablets for 14 to 28 days. Researchers will check if the ulcers heal completely within a year without needing surg…
Phase: PHASE2 • Sponsor: Barwon Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New antibiotic under safety watch for hospital superbug
Disease control Recruiting nowThis study is checking how safe the antibiotic sulbactam-durlobactam is for people hospitalized with a hard-to-treat bacterial infection called Acinetobacter baumannii. Researchers will watch 100 participants for about 28 days to see if they have any side effects, especially alle…
Sponsor: Innoviva Specialty Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can a common antibiotic stop c. diff from coming back?
Disease control Recruiting nowThis study tests whether taking oral vancomycin while on other antibiotics can prevent a repeat Clostridioides difficile infection (CDI) in people who had one in the last 120 days. Researchers will compare vancomycin to a placebo in 300 adults. Participants take the study drug tw…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New TB cocktails aim to speed up recovery
Disease control Recruiting nowThis study tests new combinations of drugs for adults with lung tuberculosis (TB). The goal is to see if these new regimens work faster and are safer than the current standard treatment. About 315 participants will receive either an experimental drug combo or the usual care for 8…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a drug cocktail slash deaths from TB of the brain?
Disease control Recruiting nowThis Phase III trial in sub-Saharan Africa tests whether giving higher doses of rifampicin plus linezolid, along with aspirin, can reduce deaths from tuberculous meningitis (TBM) in both HIV-positive and HIV-negative people. About 768 adolescents and adults will receive either th…
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Recruiting nowThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Calorie cutting may reverse a key step toward diabetes
Disease control Recruiting nowThis study investigates whether reducing calories to lower fat in the liver and muscles can improve how the body responds to insulin. Researchers will measure changes in insulin sensitivity and fat levels in 250 healthy but insulin-resistant adults with a family history of type 2…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a common antibiotic beat stubborn joint infections?
Disease control Recruiting nowThis trial investigates whether adding the antibiotic rifampicin to standard treatment improves outcomes for people with prosthetic joint infections caused by Cutibacterium acnes bacteria. These infections are hard to treat because the bacteria form a protective biofilm. The stud…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Which antibiotic wins against MRSA in the blood? new trial aims to find out
Disease control Recruiting nowThis study compares two common antibiotics, daptomycin and vancomycin, to see which one works better for adults with MRSA bloodstream infections. About 300 participants will be randomly assigned to one of the two drugs. The goal is to find which treatment leads to fewer complicat…
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could skipping a common antibiotic be just as safe for heart infections?
Disease control Recruiting nowThis study compares two antibiotic approaches for a serious heart valve infection caused by staph bacteria. One group gets a standard treatment that includes the drug rifampin, while the other group gets a treatment without it. The goal is to see if skipping rifampin is just as e…
Phase: PHASE3 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New antibiotic cocktail aimed at Drug-Resistant infections in babies
Disease control Recruiting nowThis study tests a combination of two antibiotics, aztreonam and avibactam, in newborns and infants up to 9 months old who have serious infections caused by gram-negative bacteria. The trial has two parts: one to see how a single dose moves through the body, and another to test m…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Personalized antibody therapy could tame deadly gut infections
Disease control Recruiting nowThis study tests whether giving a personalized dose of Pentaglobin (an antibody treatment) after surgery helps people with severe abdominal infection (peritonitis) and sepsis recover better. Researchers will enroll 200 patients and track organ failure and survival. The goal is to…
Phase: PHASE2 • Sponsor: RWTH Aachen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug aims to stop CMV from coming back after transplant
Disease control Recruiting nowThis study tests whether the drug letermovir can prevent cytomegalovirus (CMV) from coming back in kidney or kidney/pancreas transplant patients who are at high risk. About 90 adults will take letermovir daily for 84 days and be followed for 6 months. The goal is to see if it red…
Phase: PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope against drug-resistant lung bacteria? rifabutin trial begins
Disease control Recruiting nowThis study tests whether the antibiotic rifabutin can improve treatment for people with a stubborn lung infection caused by Mycobacterium abscessus that has become resistant to the common antibiotic clarithromycin. Researchers will enroll 60 adults with active lung disease and me…
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Dentists test if decay location determines tooth survival
Disease control Recruiting nowThis study looks at whether the position of a deep cavity (on the chewing surface or between teeth) affects how well a tooth-saving procedure called direct pulp capping works. Researchers will treat 154 people aged 15-40 with reversible pulpitis, a condition where tooth pain goes…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug aims to shield dialysis patients from deadly staph infections
Disease control Recruiting nowThis study tests a new drug called AZD7760 in healthy volunteers and people with end-stage kidney disease who are on dialysis. The goal is to see if the drug is safe and how the body processes it. If it works, it could help prevent serious staph infections that often occur in dia…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Old antibiotic, new hope: doxycycline may shield TB patients from lasting lung harm
Disease control Recruiting nowThis Phase 3 trial tests whether adding doxycycline to standard tuberculosis treatment can reduce permanent lung damage and lower the risk of heart problems. Researchers will give 150 adults either doxycycline or a placebo for 8 weeks alongside their TB medication. The main goal …
Phase: PHASE3 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a Parent's nose bacteria protect newborns from infection?
Disease control Recruiting nowThis study tests whether giving a newborn a nasal microbiome transplant from their parent can increase the diversity of bacteria in the baby's nose. The goal is to see if this can help prevent infections like those caused by Staphylococcus aureus. The study involves 175 premature…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Poop pills could tame inflamed guts in new trial
Disease control Recruiting nowThis study tests whether transplanting healthy donor stool into the gut can help people with ulcerative colitis reach remission without steroids. About 85 adults with active UC will receive either fecal transplants or a placebo. The goal is to see if a larger, definitive trial is…
Phase: PHASE1 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for kids with Drug-Resistant TB: bedaquiline trial launches
Disease control Recruiting nowThis study tests a drug called bedaquiline in children and teens (0 months to under 18 years) with multidrug-resistant tuberculosis (MDR-TB), a lung infection that does not respond to standard antibiotics. About 60 participants will receive bedaquiline along with other TB medicat…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Virus cocktail takes on superbug in Last-Resort hip infection trial
Disease control AVAILABLEThis study tests a personalized virus therapy (bacteriophage) combined with antibiotics in one patient with a chronic, drug-resistant hip joint infection. The patient has no other good options left—without treatment, the infection could be fatal or require leg amputation. The goa…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could cutting immune drugs save kidney transplants during severe infections?
Disease control Recruiting nowThis study tests whether reducing immunosuppressive drugs (along with giving a steroid) helps kidney transplant patients recover from septic shock or severe breathing failure in the ICU. About 212 adults whose transplant was at least 3 months ago will be randomly assigned to eith…
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a common antibiotic slash deaths from brain TB?
Disease control Recruiting nowThis phase 2 trial tests whether adding the antibiotic doxycycline to standard treatment can reduce deaths and severe brain damage in adults with tuberculosis of the brain or its lining. About 200 participants will receive either doxycycline or a placebo for 8 weeks, alongside us…
Phase: PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Poop pills vs antibiotics: new hope for stubborn gut infections?
Disease control Recruiting nowThis study tests whether fecal microbiota transplantation (FMT) capsules, made from healthy donor stool, can prevent C. diff infection from coming back better than standard antibiotics. About 100 adults with a first or first-recurrent C. diff infection will get either antibiotics…
Phase: PHASE3 • Sponsor: Benoit Guery • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Knee infection fight: new antibiotic injection method tested
Disease control Recruiting nowThis study tests three ways to give the antibiotic vancomycin during knee replacement surgery: into the joint, into the bone, or through a vein. The goal is to see if the simpler joint injection works as well as the others to prevent serious infections. Thirty adults having a fir…
Phase: PHASE4 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a second steroid boost survival in septic shock? tiny trial paves way
Disease control Recruiting nowThis pilot study tests whether adding fludrocortisone (a steroid pill) to standard hydrocortisone treatment helps people with septic shock. Only 32 critically ill adults will take part. The main goal is not to see if the combo works, but to check if a larger, more definitive tria…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a 2-Month TB cure replace 6 months of pills for kids?
Disease control Recruiting nowThis study tests whether a 2-month combination of four drugs can cure drug-susceptible tuberculosis in children under 10 as safely and effectively as the standard 4- to 6-month regimen. Researchers will enroll 860 children, including those with HIV, to compare the shorter treatme…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New TB combo drug trial aims to shorten treatment
Disease control Recruiting nowThis study tests whether a new drug called TBD09, when used with other TB medicines, is safe and works well in adults with drug-sensitive tuberculosis (TB). About 150 people will take part. The main goals are to see how quickly the drug combination kills TB bacteria and to check …
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a cocktail of good bacteria break the cycle of c. diff?
Disease control Recruiting nowThis large Phase 3 trial tests whether VE303, a capsule containing 8 harmless bacteria, can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had at least one prior C. diff infection will take VE303 or a placebo for 14 days. The main goal is …
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a 6-Month drug cocktail beat 9 months for brain TB?
Disease control Recruiting nowThis study compares a 6-month treatment using high doses of four antibiotics against the standard 9-month therapy for tuberculous meningitis, a serious brain infection. About 330 adults and teens without HIV will take part. The goal is to see if the shorter regimen is as safe and…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Which pneumonia vaccine works best for lymphoma patients? new study aims to find out
Disease control Recruiting nowThis study compares two pneumococcal vaccination strategies in 160 adults with lymphoma who have had chemotherapy. One group gets two vaccines (Prevenar 13 followed by Pneumovax 23), while the other gets a single newer vaccine (Prevenar 20). Researchers will measure immune respon…
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Natural prebiotic could beat antibiotics for thrush and BV
Disease control Recruiting nowThis study tests whether lactoferrin, a natural prebiotic from cow's milk, can be a good alternative to antibiotic tablets for women with bacterial vaginosis (BV) or thrush. Researchers will recruit 114 women and give half lactoferrin vaginal pessaries for 3 weeks, while the othe…
Phase: NA • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New surgical wash aims to cut joint infection risk in 7,600 replacement patients
Disease control Recruiting nowThis study tests whether a new surgical irrigation solution called XPERIENCE can lower the risk of joint infection after hip or knee replacement better than the standard dilute Betadine wash. About 7,600 adults having primary hip or knee replacement will be randomly assigned to r…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Phone alerts and support groups aim to boost treatment success for dual epidemic
Disease control Recruiting nowThis study tests four approaches to help adults with drug-resistant tuberculosis and HIV stick to their treatments. Participants receive either standard care, counseling, phone reminders via a special pill bottle, or both counseling and reminders. The goal is to see which method …
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a 100-Year-Old TB vaccine help fight a tough lung infection?
Disease control Recruiting nowThis study is testing whether the BCG vaccine, originally developed for tuberculosis, can safely treat Mycobacterium avium complex (MAC) lung disease. Researchers will give 48 adults either a single BCG injection or a placebo and monitor them for side effects, immune responses, a…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New hope for leprosy patients: experimental drug dovramilast under trial
Disease control Recruiting nowThis study tests an experimental drug called dovramilast in 45 adults with moderate to severe leprosy type 2 reaction, a painful skin condition. Participants receive either dovramilast (100 mg or 150 mg) or standard treatments like prednisolone or thalidomide. The goal is to see …
Phase: PHASE2 • Sponsor: Medicines Development for Global Health • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New combo therapy aims to beat staph blood infections
Disease control Recruiting nowThis phase 2 trial tests whether adding the antibiotic ertapenem to standard cefazolin treatment improves outcomes for adults with methicillin-susceptible Staphylococcus aureus bloodstream infections. About 60 participants will receive either the combination or a placebo. The stu…
Phase: PHASE2 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Sound waves aimed at spleen may tame deadly inflammation in septic shock
Disease control Recruiting nowThis study tests whether a non-invasive ultrasound device, aimed at the spleen, can safely reduce dangerous inflammation in people with septic shock. Septic shock is a life-threatening condition where the body's response to infection causes organ damage. Forty adults in the inten…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New nail aims to stop ankle infections in their tracks
Disease control Recruiting nowThis study is testing a new medical device called the REMEDY SPECTRUM GV IM Spacer Nail for treating ankle-related infections. About 60 adults with ankle infections will receive the nail and be followed for 6 months. The goal is to see if the nail safely clears the infection and …
Phase: PHASE2 • Sponsor: OsteoRemedies, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could more water save Kids' kidneys? new trial tests simple IV strategy
Disease control Recruiting nowThis study tests whether giving children with a severe E. coli infection extra fluids through an IV can prevent kidney failure. About 1,040 children aged 9 months to 21 years will take part. The goal is to see if this simple approach reduces the need for dialysis or long-term kid…
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a shorter antibiotic course be just as good for leg infections?
Disease control Recruiting nowThis phase 3 trial compares a 5-day course of the antibiotic flucloxacillin to the standard 7-day course for adults with leg cellulitis. About 334 participants will receive either 5 days of active drug plus 2 days of placebo, or 7 days of active drug. The goal is to see if the sh…
Phase: PHASE3 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a common ED drug and cycling help kids with duchenne?
Disease control Recruiting nowThis study is testing whether a drug called tadalafil (often used for erectile dysfunction) combined with a home cycling program can help boys with Duchenne muscular dystrophy. The drug aims to improve blood flow to muscles, which is often poor in DMD, while exercise builds stren…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Smart dosing could make MDR-TB treatment safer
Disease control Recruiting nowThis study tests whether adjusting the dose of the antibiotic linezolid based on regular blood tests can reduce harmful side effects in people being treated for multidrug-resistant tuberculosis (MDR-TB). The trial will enroll 150 patients in Guinea who are on a standard 6-month r…
Phase: PHASE4 • Sponsor: Marco Schiuma • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could oral antibiotics replace hospital stays for Syphilis-Exposed newborns?
Disease control Recruiting nowThis study tests whether oral antibiotics (linezolid or amoxicillin) can effectively treat newborns at risk of congenital syphilis, compared to a standard penicillin shot. The goal is to find a safe, outpatient-friendly option that avoids long hospital stays. The trial involves 9…
Phase: PHASE2 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New trial aims to crack code of Drug-Resistant lung bug
Disease control Recruiting nowThis clinical trial is testing different combinations of antibiotics to find the best way to treat a lung infection caused by Mycobacterium abscessus, a bacteria that is hard to kill. About 300 adults and children with this infection will receive various drug regimens, including …
Phase: PHASE2, PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a stomach bug treatment ease COPD symptoms?
Disease control Recruiting nowThis study looks at whether treating a common stomach infection (H. pylori) can improve symptoms and lung function in people with COPD. Researchers will give standard antibiotic therapy to 54 H. pylori-positive COPD patients and then measure changes in their breathing tests and s…
Phase: PHASE1 • Sponsor: Zagazig University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Antibiotics after bladder botox may cut infection risk
Disease control Recruiting nowThis study tests whether taking a short course of antibiotics (ciprofloxacin) after Botox injections into the bladder can reduce the chance of urinary tract infections. About 160 adults with neurogenic overactive bladder (due to conditions like multiple sclerosis or spinal cord i…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could adding bismuth boost stomach bug treatment?
Disease control Recruiting nowThis study tests whether adding bismuth to a 14-day course of vonoprazan and amoxicillin works better at clearing H. pylori infection than the two-drug regimen alone. About 990 adults who have not been treated before will take part. The main goal is to see which approach eradicat…
Phase: PHASE3 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Cheaper antibiotic could fight superbug typhoid
Disease control Recruiting nowThis study compares two antibiotics, azithromycin and meropenem, given through a vein to treat extensively drug-resistant enteric fever (a severe typhoid infection). Researchers will enroll 40 patients aged 1 to 70 years to see which drug clears the infection faster and reduces f…
Phase: PHASE4 • Sponsor: Indus Hospital and Health Network • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Old drug, new hope: can tinidazole beat a stubborn STI?
Disease control Recruiting nowThis study tests whether tinidazole, a drug already approved for other infections, can cure Mycoplasma genitalium in men with urethritis. About 40 men will take the medication and be checked 21 days later to see if the bacteria are gone. The goal is to find a new treatment option…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blood test strategy aims to cut TB treatment dropouts
Disease control Recruiting nowThis study tests whether regularly measuring linezolid levels in the blood can prevent dangerous side effects and keep people on their tuberculosis treatment. About 280 adults with rifampin-resistant TB will be randomly assigned to either standard care or dose adjustments based o…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New TB drug could cut treatment time by two months
Disease control Recruiting nowThis study tests whether a new drug called quabodepistat can shorten treatment for drug-resistant tuberculosis (TB) from 6 months to 4 months. About 532 adults and teens with rifampicin-resistant or multidrug-resistant TB will be randomly assigned to receive either the new shorte…
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for rare lung infection: epetraborole trial begins
Disease control Recruiting nowThis study tests a drug called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus. About 84 adults will take either a low or high dose of the drug or a placebo for 84 days. Researchers will check if symptoms improve and if the infection clears…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a pill replace the shot for syphilis?
Disease control Recruiting nowThis study compares two antibiotics for treating early syphilis: a single penicillin shot (standard care) versus a 14-day course of cefixime pills. Researchers want to see if the pill works just as well. The study includes 400 adults with early syphilis, including those with well…
Phase: PHASE3 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Cash and cameras: a new way to beat latent TB?
Disease control Recruiting nowThis study tests whether offering small financial rewards and using video calls to watch people take their medicine can help more people complete treatment for latent tuberculosis. About 399 adults in Baltimore will be randomly assigned to usual care, video check-ins alone, or vi…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
8,000-Patient trial aims to find best way to beat deadly staph blood infection
Disease control Recruiting nowThis massive international trial is testing several antibiotics and treatment strategies to find the best way to reduce deaths from Staphylococcus aureus bloodstream infections. About 8,000 hospitalized adults with a confirmed staph blood infection will be randomly assigned to di…
Phase: PHASE4 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Silver shield for hips: new implant aims to stop infections
Disease control Recruiting nowThis study tests a new hip replacement device coated with silver to see if it can prevent infections in people at high risk, such as those with diabetes or weak immune systems. About 70 participants will receive the implant and be followed for infection rates and silver safety. T…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could viruses replace antibiotics for bladder infections in spinal cord injury?
Disease control Recruiting nowThis early-stage study tests whether a mixture of viruses (called phages) that specifically kill E. coli bacteria is safe for people with spinal cord injuries who have bacteria in their bladder. Thirty adults will receive the phage solution directly into the bladder twice daily f…
Phase: PHASE1 • Sponsor: Barbara Trautner • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Gut bacteria swap could disarm superbugs in hospital patients
Disease control Recruiting nowThis study tests whether a microbiome therapy—a capsule of healthy gut bacteria—can reduce drug-resistant bacteria living in the gut of hospitalized patients. About 40 adults who carry these superbugs will receive either the therapy or a placebo. The goal is to see if the treatme…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study offers free STI care to black youth in the deep south
Disease control Recruiting nowThis study provides free testing for chlamydia, gonorrhea, syphilis, and HIV to Black youth aged 15-26 in New Orleans. Those who test positive can get treatment at no cost and are encouraged to bring their partners. The goal is to reduce STI rates and health disparities in this c…
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study tests best antibiotic for superbug infections
Disease control Recruiting nowThis study looks at 600 adults with infections caused by a hard-to-treat bacteria called Pseudomonas aeruginosa. Researchers will compare newer and older antibiotics to see which works best to cure the infection. The goal is to find the most effective treatment for these dangerou…
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Which antibiotic wins? new study tests penicillin against standard care for staph blood infection
Disease control Recruiting nowThis study tests whether penicillin works better than the usual antibiotic cloxacillin for people with a Staph blood infection that is sensitive to penicillin. About 420 adults will be randomly assigned to one of the two treatments. The main goal is to see who survives 90 days wi…
Phase: PHASE4 • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Oxygen chambers could save lives from Flesh-Eating bacteria
Disease control Recruiting nowThis study tests whether adding hyperbaric oxygen treatment (breathing pure oxygen in a pressurized chamber) to standard care can lower the death rate in people with severe, fast-spreading soft-tissue infections. About 1,480 adults with surgically confirmed infection will be rand…
Phase: PHASE4 • Sponsor: Ole Hyldegaard • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New stomach bug treatment could be simpler and smarter
Disease control Recruiting nowThis study is testing a 14-day treatment for Helicobacter pylori, a stomach infection that can cause ulcers and cancer. The treatment uses two drugs, vonoprazan and clarithromycin, and is guided by a stool test to check if the bacteria are resistant to clarithromycin. The goal is…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a shorter antibiotic course for lyme disease be just as effective?
Disease control Recruiting nowThis trial is testing whether a 7-day course of doxycycline works as well as the standard 14-day course for people with multiple erythema migrans, a sign of early Lyme disease. About 200 participants will be randomly assigned to one of the two treatment durations. Researchers wil…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Poop pills aim to break the cycle of recurrent c. diff
Disease control Recruiting nowThis study tests whether taking capsules made from healthy donor stool (fecal microbiota transplantation, or FMT) can prevent another bout of C. diff infection in people who have had it come back at least twice. 76 adults will receive either active FMT capsules or placebo, and re…
Phase: PHASE3 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope against stomach bug in Antibiotic-Resistant region
Disease control Recruiting nowThis study compares two treatments for H. pylori infection, a common stomach bug. One uses a newer drug called tegoprazan, while the other uses a standard proton pump inhibitor. The trial will enroll 400 adults in South Korea, where antibiotic resistance makes treatment difficult…
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Battle of the bacteria: which h. pylori treatment wins?
Disease control Recruiting nowThis study compares two antibiotic treatments for H. pylori, a stomach infection. 600 adults will get either a 10-day standard treatment or a 7-day treatment tailored to their bacteria's drug resistance. The goal is to see which approach eradicates the infection more effectively.
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stomach bug treatment shows promise in 14-Day trial
Disease control Recruiting nowThis study looks at how well a 14-day course of tegoprazan (a stomach acid reducer) combined with two antibiotics works to clear H. pylori infection. About 200 adults who need a stomach scope will take the treatment, and researchers will check if the bacteria are gone using a bre…
Sponsor: Soonchunhyang University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could early norepinephrine save more septic shock patients?
Disease control Recruiting nowThis study tests whether giving the drug norepinephrine early and adjusting the dose quickly can improve survival in adults with septic shock. Researchers will compare this approach to standard care with a placebo. Six hundred participants will be monitored for 28 days to see if …
Phase: NA • Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New acid blocker may beat standard treatment for stomach bug
Disease control Recruiting nowThis study tests whether a newer acid-reducing drug (vonoprazan) works better than a standard one (esomeprazole) for clearing H. pylori, a bacteria that can cause stomach ulcers and indigestion. About 80 adults with H. pylori will take one of the two drug combinations for 14 days…
Phase: PHASE4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New calculator could help sick newborns get the right antibiotic dose faster
Disease control Recruiting nowThis study tests whether using early drug monitoring and a dose-adjustment calculator can help infants under 90 days old with sepsis reach target vancomycin levels more quickly. Currently, doctors must wait 24-48 hours to check drug levels, which can delay effective treatment. Th…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could a new blood filter save more lives in septic shock?
Disease control Recruiting nowThis study looks at whether a special blood filter called oXiris helps people with septic shock and kidney failure survive. Researchers will review medical records of 360 adults in the ICU who needed continuous blood filtering. They will compare those who got the oXiris filter wi…
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could a Two-Drug cocktail beat the standard Four-Drug regimen for stomach bug?
Disease control Recruiting nowThis study tests whether a 14-day course of just two medications (vonoprazan and amoxicillin) works as well as the usual four-drug combination for eradicating H. pylori, a bacteria that can cause stomach ulcers and cancer. About 372 adults with a confirmed H. pylori infection who…
Phase: NA • Sponsor: Yanqing Li • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Personalized antibiotics may beat standard therapy for stubborn stomach bug
Disease control Recruiting nowThis study tests whether choosing antibiotics based on lab tests of the bacteria works better than standard antibiotic combinations for people whose H. pylori infection hasn't been cured before. About 450 adults will receive either a tailored or standard regimen for 14 days. The …
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a simple pill replace IV drips for blood infections?
Disease control Recruiting nowThis study tests whether stable patients with a common blood infection (gram-negative bacteraemia) can safely switch from IV antibiotics to oral pills within 72 hours. Researchers will compare early oral therapy to continued IV treatment in 720 adults. The main goal is to see if …
Phase: PHASE4 • Sponsor: Tan Tock Seng Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a simple salt solution save lives in septic shock?
Disease control Recruiting nowThis study compares two fluids—sodium lactate and a concentrated saline solution—in 40 adults with septic shock. The goal is to see which one better supports blood flow and acid balance. Participants will receive either fluid in a double-blind setup, and researchers will measure …
Phase: PHASE2 • Sponsor: University Hospital Pilsen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can plasma transfusion and blood filtering save lives in leptospirosis?
Disease control Recruiting nowThis study tests whether plasma transfusion and a blood-filtering procedure called hemoperfusion can prevent lung damage and death in people with leptospirosis, a bacterial infection spread by animals. Researchers will also check if a blood marker called CFI can predict who will …
Phase: PHASE2 • Sponsor: National Kidney and Transplant Institute, Philippines • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New study aims to improve repeat eyelid surgery for trichiasis in east africa
Disease control Recruiting nowThis trial tests two surgical methods for repeat eyelid surgery in people with trichiasis, a condition where eyelashes rub against the eye. About 1,000 participants in Tanzania will receive either the B-RAP or BLTR procedure. The goal is to see which technique better prevents eye…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for blood cancer patients: drug aims to slash infection risk
Disease control Recruiting nowThis study tests whether a medicine called XEMBIFY, given every two weeks alongside standard care, can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody lev…
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Stomach bug treatment may boost metabolic health, study investigates
Disease control Recruiting nowThis study looks at whether treating Helicobacter pylori (Hp), a common stomach infection, can also help improve metabolic syndrome (high blood sugar, cholesterol, and weight). Researchers will give standard Hp treatment alone or with probiotics or berberine to 120 adults. They w…
Phase: PHASE4 • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a 7-Day cocktail beat h. pylori? new trial tests shorter fix
Disease control Recruiting nowThis study tests whether a 7-day combination of vonoprazan, high-dose amoxicillin, and bismuth can effectively eradicate H. pylori bacteria in the stomach. About 316 adults with a first-time H. pylori infection will be randomly assigned to either the 7-day triple therapy or a sta…
Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New Pig-Skin dressing could speed healing of Flesh-Eating wounds
Disease control Recruiting nowThis study tests a special wound dressing made from pig tissue (Cytal Wound Matrix and MicroMatrix) to see if it helps heal wounds from necrotizing fasciitis (a severe flesh-eating infection) faster than standard dressings. Fifty adults with large wounds (at least 30 cm²) will be…
Phase: NA • Sponsor: Benjamin T. Miller • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a zap to the ear tame sepsis?
Disease control Recruiting nowThis pilot study tests whether a mild electrical pulse to the ear (vagus nerve stimulation) can reduce inflammation and improve heart rate balance in people with septic shock. 34 participants will be randomly assigned to receive either active stimulation or a sham (placebo) for 4…
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a simple antibiotic stop shigella from stunting Kids' growth?
Disease control Recruiting nowThis study looks at whether giving antibiotics to children with a certain type of Shigella infection (non-dysentery watery diarrhea) helps them recover faster and grow better. About 700 children in Bangladesh and Zambia will receive either azithromycin or a placebo. Researchers w…
Phase: PHASE2 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could cutting back on IV fluids save lives in septic shock?
Disease control Recruiting nowThis study is testing whether giving fewer non-essential fluids to adults with septic shock can improve outcomes. The trial will enroll 1,850 patients in intensive care, comparing a restrictive fluid strategy to usual care. The main goal is to see if this approach reduces deaths …
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study tests if pulmonary rehab can prevent Long-Term lung damage after TB
Disease control Recruiting nowThis study tests whether an 8-week or 24-week pulmonary rehabilitation program (exercise and breathing training) helps people recover lung function after completing tuberculosis (TB) treatment. About 690 adults with confirmed TB will be randomly assigned to one of two rehab progr…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Blue dye could save lives in sepsis? new trial launches
Disease control Recruiting nowThis study tests if a medicine called methylene blue can help improve blood flow in patients with septic shock, a severe infection that causes dangerously low blood pressure. About 50 adults will receive either methylene blue or standard care for 3 days. The main goal is to see i…
Phase: PHASE2, PHASE3 • Sponsor: Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy aims to beat staph blood infections
Disease control Recruiting nowThis study tests whether adding the antibiotic linezolid to standard treatment improves outcomes for people with Staphylococcus aureus bloodstream infections. About 606 hospitalized adults will receive either linezolid or a placebo for five days. The goal is to see if the combina…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New decision tool aims to catch childhood TB earlier in africa
Disease control Recruiting nowThis study tests a new way to help doctors in Mozambique and Zambia decide if a sick child has tuberculosis (TB). The approach uses simple checklists and decision guides, supported by a computer system, to improve diagnosis and treatment, especially for children with HIV or sever…
Phase: NA • Sponsor: Chishala Chabala • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Knee infection breakthrough? one surgery may replace two
Disease control Recruiting nowThis study tests whether a single surgery to replace an infected artificial knee works as well as the standard two-surgery approach. About 153 patients with a chronic knee infection will be randomly assigned to one of the two treatments. Researchers will track pain, function, and…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a common blood thinner help fight staph infections?
Disease control Recruiting nowThis study looks at whether switching to the blood thinner dabigatran can improve outcomes for people with a serious staph bloodstream infection who are already taking other blood thinners. Researchers will compare those who switch to dabigatran with those who stay on their curre…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Could a common heart drug fight staph infections too?
Disease control Recruiting nowThis study looks at whether switching from aspirin to clopidogrel (another blood thinner) can reduce heart complications in people with a serious staph bloodstream infection. About 300 adults already taking aspirin for heart disease will be randomly assigned to stay on aspirin or…
Phase: PHASE4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Phage therapy takes on superbug UTIs in new trial
Disease control Recruiting nowThis study tests a new treatment called LBP-EC01, which uses specially designed viruses (bacteriophages) to attack drug-resistant E. coli bacteria that cause urinary tract infections (UTIs). About 318 adults with a history of UTIs and a current infection will receive either LBP-E…
Phase: PHASE2 • Sponsor: Locus Biosciences • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Antibiotic shot under skin could replace IV drip for serious infections
Disease control Recruiting nowThis study is testing whether a powerful antibiotic called piperacillin/tazobactam can be given as a continuous shot under the skin instead of through an IV line. About 240 adults with serious bacterial infections will be randomly assigned to receive the drug either subcutaneousl…
Phase: PHASE2 • Sponsor: Azienda Sanitaria Universitaria Friuli Centrale • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for Kids' diarrhea: drug plus fluids tested
Disease control Recruiting nowThis study tests how the drug rifaximin (Xifaxan) works in children aged 6 to 11 with acute diarrhea likely caused by bacteria. Half the children get the drug plus oral rehydration therapy, the other half get rehydration alone. Researchers want to see if adding the drug helps dia…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Multiple fecal transplants may beat single dose for c. diff in colitis patients
Disease control Recruiting nowThis study tests whether giving several fecal transplants (instead of just one) works better to clear repeat C. diff infections in people with ulcerative colitis. About 64 adults with active colitis and repeat C. diff will receive either one or multiple infusions of healthy donor…
Phase: PHASE1, PHASE2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New antibiotic eye drops aim to cure pink eye faster
Disease control Recruiting nowThis phase 3 trial tests whether fusidic acid 1% eye drops can cure bacterial conjunctivitis (pink eye) better than a placebo. About 400 adults and children with confirmed bacterial infection will receive either the antibiotic or placebo drops for a short time. The study measures…
Phase: PHASE3 • Sponsor: Baxis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study tests best way to deliver antibiotic combo against superbugs
Disease control Recruiting nowThis study is testing two different ways of giving a combination of two antibiotics (ceftazidime-avibactam and aztreonam) to treat serious infections caused by bacteria that are resistant to many drugs. The researchers want to see if giving the drugs one after the other works as …
Phase: PHASE4 • Sponsor: Jing Zhou • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Virus cocktail fights deadly heart infection in new trial
Disease control Recruiting nowThis study tests whether adding a special virus mixture (phage therapy) to standard antibiotics can improve outcomes for people with a serious heart valve infection called infective endocarditis. About 30 participants will receive either the phage therapy or a placebo alongside t…
Phase: PHASE3 • Sponsor: University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a Heart-Lung machine save kids with septic shock?
Disease control Recruiting nowThis study tests whether a heart-lung bypass machine (ECMO) can help children with severe septic shock survive. Researchers will enroll 60 children and track how many leave the hospital alive. They also want to find the best time to start ECMO and which factors affect success.
Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New study aims to pinpoint optimal timing of vasopressin in septic shock
Disease control Recruiting nowThis study tests whether giving the drug vasopressin earlier or later during septic shock leads to better outcomes. Researchers will use a computer alert system to randomly assign 300 ICU patients to early or standard timing. The goal is to see if the timing can be reliably contr…
Phase: PHASE4 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a simple pill replace IV drips for serious blood infections?
Disease control Recruiting nowThis study compares two ways to treat Gram-negative bloodstream infections: staying on IV antibiotics versus switching to oral pills early. Researchers want to see if the oral option works just as well but causes fewer side effects. About 1,030 hospitalized adults will take part,…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug could help ER patients with severe infection shock
Disease control Recruiting nowThis pilot study tests whether giving angiotensin II early in the emergency department can help stabilize blood pressure in patients with septic shock. Twenty adults who need a standard drug called norepinephrine will receive angiotensin II as an add-on. The main goal is to see i…
Phase: PHASE4 • Sponsor: Brett A Faine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New gel may stop shoulder implant infections in men
Disease control Recruiting nowThis study tests whether applying Prontosan antimicrobial gel to the skin during shoulder replacement surgery can reduce bacteria that might cause infections. It involves 60 adult men having their first shoulder replacement. Researchers will compare infection-related bacteria lev…
Phase: NA • Sponsor: St. Louis University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Poop pills fight superbug infections!
Disease control AVAILABLEThis study provides a fecal transplant product made from healthy donor stool to treat people with recurrent Clostridium difficile infection or multidrug-resistant urinary tract infections. The product is delivered by courier or FedEx after a contract is signed. The goal is to res…
Sponsor: Herbert DuPont, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a simple pill replace the IV drip for ER infections?
Disease control Recruiting nowThis study tests whether giving oral antibiotics instead of IV antibiotics is just as safe and effective for patients with common infections like pneumonia, urinary tract infections, and cellulitis. About 4,000 adults in Danish emergency rooms will be randomly assigned to start o…
Phase: NA • Sponsor: University of Southern Denmark • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a simple drink mix keep UTIs away? new trial seeks answers
Disease control Recruiting nowThis 6-month study tests whether a daily D-Mannose drink mix (FLUSH) can help women with a history of recurrent UTIs have fewer infections and better urinary health. About 210 adult women will be randomly assigned to one of three groups. Researchers will track how long it takes f…
Phase: NA • Sponsor: Bonafide Health • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Probiotics may boost recovery after joint infection surgery
Disease control Recruiting nowThis study tests whether taking a daily probiotic capsule (Lactobacillus rhamnosus GG) for six weeks after surgery can improve immune markers and recovery in people treated for a hip or knee joint infection. About 152 adults aged 18–90 will be enrolled. Researchers will measure b…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New injection could fight stubborn joint infections after knee surgery
Disease control Recruiting nowThis early-phase trial tests a new drug called TNP-2092, given as an injection into the knee joint, for people with infections after knee replacement surgery. The study includes 33 participants and compares the new drug to standard antibiotics. The main goal is to check safety an…
Phase: PHASE1, PHASE2 • Sponsor: TenNor Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could two steroids slash septic shock deaths?
Disease control Recruiting nowThis study tests whether giving two steroids—hydrocortisone and fludrocortisone—for up to 7 days can lower the risk of death in adults with septic shock. About 336 patients will be randomly assigned to receive either the steroid combo or standard care alone. The main goal is to s…
Phase: PHASE4 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New antibiotic combo tested in kids to fight superbug infections
Disease control Recruiting nowThis study is testing an antibiotic called Sulbactam-Durlobactam in hospitalized children from birth to under 18 years old who have or may have an Acinetobacter infection. The goal is to find the right dose and check that it is safe. About 48 children will receive the drug throug…
Phase: PHASE1 • Sponsor: Innoviva Specialty Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Argon plasma zaps stomach bugs in new trial
Disease control Recruiting nowThis study tests a new way to treat H. pylori, a bacteria that can cause stomach ulcers and cancer. During an endoscopy, doctors fill the stomach with a saltwater solution that is activated by argon plasma to kill the bacteria. The trial will compare two methods of making this so…
Phase: NA • Sponsor: Christopher C. Thompson, MD, MSc • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
Disease control Recruiting nowThis study tests a new drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily for up to 28 days alongside standard care. The goal is to see if it is safe and helps patients recover faster from pneumonia caused by COVID-19 or ot…
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Custom 3D-Printed hip implants offer new hope for failed arthritis surgeries
Disease control Recruiting nowThis study tests custom-made, 3D-printed hip implants for 15 adults whose previous hip replacements failed due to severe bone loss or infection. The implants are designed from CT scans to fit each person's unique bone damage. Researchers will track complications, pain, mobility, …
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a contraceptive gel ward off vaginal infections?
Disease control Recruiting nowThis early study tests whether a lactic acid gel (Phexxi) used twice weekly can change the vaginal microbiome to help prevent recurrent bacterial vaginosis and yeast infections. 22 premenopausal women with a history of these infections will use the gel for 4 weeks. Researchers wi…
Phase: EARLY_PHASE1 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Poop pills? no, stool transplants aim to cure recurrent c. diff
Disease control Recruiting nowThis study is testing whether transplanting stool from a healthy donor into the colon can prevent recurrent C. diff infections. The procedure, done via colonoscopy, aims to restore good bacteria that keep C. diff in check. Researchers are tracking 500 people to see if this stops …
Phase: NA • Sponsor: Krunal Patel • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Lymph drainage may cool overactive immune response in sepsis
Disease control Recruiting nowThis early study tests whether draining lymph fluid from the chest can lower harmful inflammation in people with septic shock. Ten adults in the surgical ICU will have a tube placed in their thoracic duct to drain lymph for up to 7 days. The goal is to see if this procedure is sa…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study tests which Tooth-Saving technique works best for deep cavities
Disease control Recruiting nowThis study compares two dental procedures to treat deep cavities in back molars that have moderate pulpitis (inflamed tooth nerve). In one method, the dentist removes only part of the decay and places a protective material over the remaining decay. In the other, all decay is remo…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a 4-Month TB regimen work as well as 6 months?
Disease control Recruiting nowThis study tests whether people with asymptomatic tuberculosis (TB) can be treated effectively with a shorter course of standard antibiotics—17 weeks instead of the usual 6 months. Researchers will compare the shorter regimen to standard treatment in 426 participants in China. Th…
Phase: PHASE4 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy could beat stubborn stomach bug
Disease control Recruiting nowThis study tests a newer acid-blocking drug (vonoprazan) against a standard one, each combined with vitamin D or probiotics, to treat H. pylori infection. About 66 adults with confirmed H. pylori will receive one of three treatments for two weeks. The goal is to see which combina…
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could 2 days of antibiotics be enough for deadly Flesh-Eating infections?
Disease control Recruiting nowThis study compares a 48-hour course of antibiotics to a standard 7-day course for people with severe, life-threatening skin infections called necrotizing soft tissue infections. Researchers want to see if the shorter treatment is just as safe and effective. The trial will enroll…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New blood purification therapy for sepsis under Real-World scrutiny
Disease control Recruiting nowThis registry study is following 200 adults with sepsis or septic shock who receive ARTICE® therapy in the ICU. Researchers are tracking organ function, survival, and complications to see how well the treatment works in everyday practice. The goal is to identify which patients be…
Sponsor: Artcline GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Massive trial aims to outsmart superbugs in blood infections
Disease control Recruiting nowThis study compares different antibiotic strategies for people hospitalized with Gram-negative bloodstream infections. The goal is to find which approach leads to better outcomes, like survival and fewer complications, while also reducing the risk of antibiotic resistance. About …
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New antibiotic dosing method could help sepsis patients recover faster
Disease control Recruiting nowThis study compares two ways of giving the antibiotic cefepime to very sick patients with sepsis in the ICU. The new method adjusts the dose based on the patient's kidney function, using only standard doses. The main goal is to see if this approach is easy for doctors to use and …
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New antibiotic combo vaborem tested in kids for tough infections
Disease control Recruiting nowThis study is testing the safety and how the body handles Vaborem, a combination of two antibiotics (meropenem and vaborbactam), in children from birth to under 18 years old who have serious Gram-negative bacterial infections. All 44 participants will receive the drug intravenous…
Phase: PHASE2 • Sponsor: Menarini Group • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for Drug-Resistant TB: experimental combo trial launches
Disease control Recruiting nowThis study tests a new drug called JDB0131, combined with other TB medications, in 60 people with rifampin-resistant tuberculosis. Participants will receive one of two doses of JDB0131 or a standard drug (delamanid) for 8 weeks. The goal is to see which combination clears the bac…
Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New trial tests best timing for sepsis drug to save lives and kidneys
Disease control Recruiting nowThis study tests whether giving vasopressin early, along with norepinephrine, is better than waiting to use it as a rescue treatment for people with septic shock. About 2,800 critically ill adults will be randomly assigned to one of two strategies. The main goal is to see which a…
Phase: PHASE3 • Sponsor: Hospital do Coracao • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New antibiotic cocktail aims to delay preterm birth after water breaks
Disease control Recruiting nowThis study tests whether a 7-day course of three antibiotics (ceftriaxone, clarithromycin, metronidazole) can prolong pregnancy better than the current standard antibiotics in pregnant people hospitalized after their water breaks early (before 34 weeks). About 56 participants wil…
Phase: PHASE4 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can charcoal speed up poison recovery? new study aims to find out
Disease control Recruiting nowThis pilot study is testing whether giving activated charcoal within 6 hours of swallowing a poisonous substance can prevent the poison from getting worse and shorten hospital stays. About 100 adults and children who have ingested a substance that charcoal can absorb will be rand…
Phase: PHASE4 • Sponsor: Laval University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Urine test could personalize TB treatment and save lives
Disease control Recruiting nowThis study tests whether adjusting the dose of the TB drug rifampin based on a simple urine test can improve treatment outcomes. Researchers will enroll 200 adults and children with active, drug-sensitive tuberculosis in Tanzania. The goal is to see if personalized dosing helps m…
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a simpler dosing method for MRSA work just as well?
Disease control Recruiting nowThis study tests whether a simpler way of dosing the antibiotic vancomycin (targeting a trough level of 10-15 mg/L) works as well as the more complex method (targeting AUC/MIC 400-600) for treating serious MRSA infections. About 700 adults with infections like bloodstream, lung, …
Phase: NA • Sponsor: Anthony Bai • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New triple therapy could simplify h. pylori treatment
Disease control Recruiting nowThis study compares two 14-day antibiotic treatments for Helicobacter pylori infection, a common stomach bug that can cause ulcers. The triple therapy uses bismuth, amoxicillin, and vonoprazan, while the quadruple therapy adds rabeprazole, tetracycline, and metronidazole. Researc…
Phase: NA • Sponsor: Kaohsiung Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New trial aims to outsmart superbug in ICU patients
Disease control Recruiting nowThis study tests three different antibiotic combinations to treat a dangerous, drug-resistant bacteria called CRAB that causes infections in intensive care patients. Researchers will compare colistin combined with either fosfomycin, ampicillin/sulbactam, or eravacycline in 108 su…
Phase: PHASE4 • Sponsor: Clinical Hospital Centre Zagreb • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New score could help doctors spot fungal pneumonia faster
Diagnosis Recruiting nowThis study aims to create and test a clinical prediction score called FUNGAL-P to help doctors identify fungal pneumonia early in adults who come to the hospital with pneumonia. Researchers will analyze medical records from past patients and then test the score on new patients to…
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Diagnosis
Last updated Jul 03, 2026 23:00 UTC
-
New rapid gonorrhea test could speed up diagnosis
Diagnosis Recruiting nowThis study is testing a new rapid test for gonorrhea called the iStatis Gonorrhea Antigen Test. The test uses a vaginal swab and gives results quickly at the clinic. Researchers want to see how accurate and easy it is to use when performed by trained staff. About 650 women will t…
Phase: NA • Sponsor: bioLytical Laboratories • Aim: Diagnosis
Last updated Jul 03, 2026 23:00 UTC
-
New blood test aims to predict sepsis in minutes, not hours
Diagnosis Recruiting nowThis study tests whether measuring a substance called IL-6 in the blood can quickly predict if an emergency room patient with a suspected infection will develop sepsis or septic shock. Researchers will enroll 450 adults admitted from the ER and track their outcomes for up to 30 d…
Sponsor: Bluejay Diagnostics, Inc. • Aim: Diagnosis
Last updated Jul 03, 2026 23:00 UTC
-
Swallow a string to test for stomach bug?
Diagnosis Recruiting nowThis study tests a new device called the esophageal string test (EST) to diagnose H. pylori, a stomach bacteria that can cause ulcers and cancer. Participants swallow a capsule with a string inside that collects stomach fluids. Researchers compare the results to standard tests. T…
Phase: NA • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
AI eye on stomach cancer: 6,000-Person trial tests smarter scopes
Diagnosis Recruiting nowThis study tests whether artificial intelligence (AI) can help doctors better detect H. pylori infection and precancerous stomach changes during routine endoscopy. The goal is to see if AI assistance can reduce deaths from stomach cancer. The trial will enroll 6,000 adults aged 2…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Urine test may spot kidney danger early in septic shock
Diagnosis Recruiting nowThis study investigates whether a urine test called Nephrocheck can predict which patients with septic shock will develop severe acute kidney injury. The test measures two markers of kidney damage (TIMP2 and IGFBP7). Researchers will analyze data from previous studies involving a…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Phone AI could spot eye disease in remote areas
Diagnosis Recruiting nowThis study tests a smartphone app that uses artificial intelligence to detect 16 different eye diseases from photos taken with the phone. The AI works entirely on the device, so no internet is needed. Researchers will compare its accuracy to eye doctors and see if non-medical use…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Newborn infection risk detected in hours with Light-Based score
Diagnosis Recruiting nowThis study tests a new, non-invasive tool called the POP-Score to predict infection in newborns within the first 6 hours of life. The score combines light-based measurements of muscle oxygen with routine vital signs like heart rate and blood pressure. Researchers will enroll 93 n…
Sponsor: Medical University of Graz • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New blood test could spot hidden belly infections faster
Diagnosis Recruiting nowThis study is testing a new blood test that looks at RNA (genetic material) to quickly tell if a person with belly pain has an infection inside the abdomen, like appendicitis or diverticulitis. About 1,000 adults and children over age 7 with abdominal pain will give a blood sampl…
Sponsor: True Bearing Diagnostics, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Mouth ultrasound could slash unnecessary throat punctures
Diagnosis Recruiting nowThis study compares two ways to diagnose a peritonsillar abscess (a pus pocket near the tonsils): the usual physical exam versus adding a small ultrasound probe inside the mouth. About 368 adults with suspected abscess will take part. The goal is to see if ultrasound improves acc…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
ER syphilis screening for pregnant women could save lives
Diagnosis Recruiting nowThis study aims to increase syphilis testing and treatment for pregnant women who haven't had prenatal care or a syphilis test during their pregnancy. Researchers will offer rapid point-of-care tests in the emergency department and obstetrical triage, then help connect those who …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Your phone's mic could detect TB in seconds: new trial recruits 1,751
Diagnosis Recruiting nowThis study tests whether a smartphone app can tell the difference between a TB cough and other coughs by analyzing audio recordings. Researchers will collect cough sounds from 1,751 people with a cough lasting at least two weeks, then use machine learning to build a quick screeni…
Sponsor: University of Stellenbosch • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Massive global study aims to slash TB deaths with smarter testing
Diagnosis Recruiting nowThis study aims to find faster, simpler, and cheaper ways to diagnose tuberculosis (TB), a disease that kills over a million people each year. Researchers will test new diagnostic tools on over 26,000 adults in 10 countries who have a cough lasting two weeks or more, or who have …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New rapid test could detect three infections at once
Diagnosis Recruiting nowThis study is testing a new rapid diagnostic device called TruPlex that can detect HIV, Hepatitis B, and Syphilis from a small blood sample. Researchers will enroll 1000 adults at risk for these infections to see how accurate and easy the test is to use in clinics and point-of-ca…
Phase: NA • Sponsor: bioLytical Laboratories • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New blood test aims to spot lyme disease in kids faster and more accurately
Diagnosis Recruiting nowThis study aims to develop a better blood test for early Lyme disease in children. Current tests often miss early infections or give false positives. Researchers will also study the immune response and the types of Lyme bacteria involved. About 500 children with suspected Lyme di…
Sponsor: University Children's Hospital, Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New blood test could speed up TB diagnosis
Diagnosis Recruiting nowThis study is testing whether measuring TB DNA in blood and urine can help diagnose tuberculosis and track treatment progress. Current TB tests can be slow or require invasive procedures. The trial will enroll 85 people with active TB, latent TB, or no TB to see how accurate the …
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Simple blood test could save babies from unnecessary antibiotics
Diagnosis Recruiting nowThis pilot study tests a new blood test that looks at markers on white blood cells to tell if a feverish baby under 3 months has a serious bacterial infection. Researchers will collect an extra small blood sample from 180 infants in the emergency department. The goal is to see if…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New rapid test could transform gonorrhea detection for pregnant women
Diagnosis Recruiting nowThis study is testing a new, quick test for gonorrhea in pregnant women and women with symptoms in South Africa. About 1,239 women will provide samples to see if the new test works as well as standard lab methods. The goal is to make diagnosis faster and easier, especially in cli…
Sponsor: Foundation for Professional Development (Pty) Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
AI reads your gut scans to spot disease without a scope
Diagnosis Recruiting nowThis study is developing an artificial intelligence system that analyzes CT and MRI scans to diagnose and predict outcomes for digestive diseases like Crohn's disease, ulcerative colitis, and intestinal tuberculosis. Researchers are using data from 21 hospitals in China to train …
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New ultrasound and DNA test could revolutionize leprosy diagnosis
Diagnosis Recruiting nowThis study is testing whether a new approach—using ultrasound to guide a tiny needle to collect fluid near the ulnar nerve, then analyzing it for leprosy bacteria DNA—can more accurately diagnose leprosy and confirm when it's cured. Researchers will follow 108 participants for on…
Phase: NA • Sponsor: University of Brasilia • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New DNA test could spot hidden TB in chest fluid, reducing invasive procedures
Diagnosis Recruiting nowThis study is testing a new laboratory method that looks for DNA fragments from tuberculosis bacteria in fluid around the lungs (pleural effusion). The goal is to see if this test can diagnose tuberculous pleurisy more accurately than current tests. Researchers will study 400 adu…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New scan could reveal hidden lung damage in TB survivors
Diagnosis Recruiting nowThis study is testing whether a special PET scan tracer called 18F-FAPI-74 can detect scarring (fibrosis) in the lungs of people with active tuberculosis. About 30 adults with confirmed TB will get the tracer and a whole-body PET/CT scan during and after treatment. The goal is to…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Could an AI device replace the Doctor's visit for kids with ear infections and asthma?
Diagnosis Recruiting nowThis study tests a new device that uses artificial intelligence to help diagnose ear infections, strep throat, and asthma flare-ups in children. About 84 kids aged 3 to 17 will either use the device at home with a doctor's video visit or receive standard in-person care. The goal …
Phase: NA • Sponsor: Medentum Innovations • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New dye test could spot Flesh-Eating bacteria in minutes
Diagnosis Recruiting nowThis study tests whether a safe, FDA-approved dye called indocyanine green (ICG) can help doctors quickly tell the difference between a life-threatening flesh-eating infection (necrotizing fasciitis) and a less dangerous skin infection. About 420 adults with suspected infections …
Sponsor: Eric R. Henderson • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Could a swab or a cough sound diagnose TB in kids?
Diagnosis Recruiting nowThis study is testing new, non-invasive ways to diagnose tuberculosis (TB) in children under 15. Researchers will evaluate oral swabs, cough sound analysis, and lung sound analysis as potential alternatives to sputum tests. The goal is to find faster, simpler, and cheaper diagnos…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Could a tongue swab replace sputum tests for TB?
Diagnosis Recruiting nowEvery year, millions of people with tuberculosis (TB) go undiagnosed. This study tests new, faster diagnostic tools that use a simple tongue swab instead of the usual sputum sample. Researchers will enroll 1,350 adults with cough or TB risk factors to see how accurate these point…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New tests aim to outsmart superbug gonorrhea
Diagnosis Recruiting nowThis study is testing three new diagnostic tests to see if they can correctly identify a gene mutation that makes gonorrhea resistant to the antibiotic ciprofloxacin. Researchers will use leftover samples from over 3,000 people who already tested positive for gonorrhea. If the te…
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Stool test may detect stomach cancer risk before symptoms appear
Diagnosis Recruiting nowThis study is testing a new, non-invasive stool test that looks for specific gene changes in H. pylori bacteria linked to stomach cancer. Researchers will compare the test's accuracy with a standard risk questionnaire in 15,000 adults aged 40 and older. The goal is to see if this…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Could new syphilis tests speed up diagnosis?
Diagnosis Recruiting nowThis study is testing two new blood test kits designed to diagnose syphilis. Researchers will collect blood samples from 1000 people, including those with symptoms, those at high risk, and healthy controls. The goal is to see how accurate these new kits are compared to standard l…
Sponsor: American Laboratory Products Company • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New PET scan aims to spot hidden scar tissue
Diagnosis Recruiting nowThis study tests a special PET/CT scan that uses a tracer called FAPI-74 to find fibrosis (scar-like tissue) in the body. It includes 45 adults with conditions like head and neck cancer or tuberculosis that can cause fibrosis. The goal is to see how well the scan shows fibrosis, …
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New scan could light up hidden infections
Diagnosis Recruiting nowThis early study is testing a radioactive tracer called [18F]F-TMP that is injected into the body and then tracked with a PET/CT scan. The goal is to see if the tracer collects at sites of bacterial infection, making them visible on the scan. Twenty adults with known or suspected…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Blood test may predict sepsis death risk within 28 days
Diagnosis Recruiting nowThis study is testing whether measuring a substance called IL-6 in the blood can help predict which patients with sepsis or septic shock are most likely to die within 28 days. Researchers will enroll 700 adults in intensive care units (ICUs) and follow them for 28 days. If the te…
Sponsor: Bluejay Diagnostics, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Heat-Sensing camera could speed up infection diagnosis in kids
Diagnosis Recruiting nowThis study explores whether a special thermal camera can help doctors quickly detect infections in children's bones, joints, or soft tissues. About 30 children with suspected infections will have a 10-second video taken of the affected area to see if the heat pattern matches the …
Sponsor: Sheffield Children's NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
One test, four diseases: could this be the end of missed diagnoses?
Diagnosis Recruiting nowThis study tests a new device called MagIA H3S that can screen for HIV, hepatitis B, hepatitis C, and syphilis using a single blood sample. Researchers will enroll about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab tests. If it …
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New blood test aims to detect hidden infections in vulnerable patients
Diagnosis Recruiting nowThis study is testing whether a blood test called Karius Spectrum can help doctors find infections faster in adults with weakened immune systems (e.g., organ transplant recipients, cancer patients). The test looks for DNA from bacteria, fungi, viruses, and parasites in the blood.…
Phase: NA • Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Can a simple finger-prick test help find hidden HIV and syphilis cases?
Diagnosis Recruiting nowThis study checks if a new self-test for HIV and syphilis is accurate and easy for people to use at home. About 900 adults in Canada will try the test and compare results to lab tests. The study also looks at how peer support can help homeless people in Toronto get tested and tre…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
DNA test could revolutionize treatment for Drug-Resistant TB
Diagnosis Recruiting nowThis study tests whether a DNA sequencing test can help doctors choose the right antibiotics for people with drug-resistant tuberculosis (TB). Researchers will collect samples from 2,500 participants in clinics and use targeted sequencing to identify which drugs the TB bacteria a…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
New test aims to stop unnecessary antibiotics for respiratory infections
Diagnosis Recruiting nowThis study is testing a new diagnostic tool that helps doctors quickly tell if a respiratory infection is caused by bacteria or a virus. The goal is to see if using this test leads to better treatment decisions, fewer unnecessary antibiotics, and lower healthcare costs. About 100…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Could a simple STI test prevent preterm birth?
Prevention Recruiting nowThis study will test whether screening pregnant women for chlamydia and gonorrhea can reduce the risk of preterm birth. About 2,000 women in Botswana will be randomly assigned to receive either standard care or additional STI testing early in pregnancy and again in the third trim…
Phase: NA • Sponsor: Adriane Wynn • Aim: Prevention
Last updated Jul 03, 2026 23:00 UTC
-
Can a simple vancomycin taper beat a pricey drug for recurrent c. diff?
Prevention Recruiting nowThis phase 3 trial tests whether a gradual taper of vancomycin is as good as a 10-day course of fidaxomicin at preventing another C. difficile infection. About 500 adults with a first or second C. diff episode will be randomly assigned to one of the two treatments. The main goal …
Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
Can a single shot stop c. diff from returning?
Prevention Recruiting nowThis study tests a new drug called AZD5148 to see if it can prevent repeat C. diff infections in adults. About 230 people will get either the drug or a placebo as a single injection. The goal is to stop the infection from coming back after standard treatment.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
One shot or two? study tests best way to give tdap and RSV vaccines in pregnancy
Prevention Recruiting nowThis study is looking at whether it's safe and effective to give the Tdap vaccine (for whooping cough) and the RSV vaccine at the same doctor's visit during pregnancy, or if they should be given separately. The researchers will recruit 60 healthy pregnant individuals and randomly…
Phase: PHASE4 • Sponsor: Canadian Immunization Research Network • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
STI tests boost HIV prevention in pregnant women
Prevention Recruiting nowThis study in Botswana tests whether offering sexually transmitted infection (STI) testing alongside HIV prevention medication (PrEP) helps more pregnant women start and continue using PrEP. About 600 pregnant women without HIV will be split into two groups: one gets standard car…
Phase: PHASE3 • Sponsor: Botswana Harvard AIDS Institute Partnership • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Your dinner plate might fight c. diff: diet study aims to stop repeat infections
Prevention Recruiting nowThis study tests whether a specific diet can change gut bacteria and help prevent another C. difficile infection in adults who have had one. Twenty participants will receive prepared meals and health counseling, then follow a similar diet for 6 more weeks. Researchers will track …
Phase: NA • Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
4-Week TB pill could replace months of treatment for millions at risk
Prevention Recruiting nowThis study tests whether a 4-week course of the drug bedaquiline can prevent tuberculosis (TB) as well as standard longer treatments. It involves 2,530 people living with HIV and close contacts of TB patients. The goal is to find a safer, easier-to-complete prevention option.
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Penicillin shots tested to stop syphilis in pregnancy
Prevention Recruiting nowThis study tests whether giving penicillin shots to pregnant women at high risk for syphilis can prevent infection. Researchers in Rio de Janeiro will enroll 500 women and compare the shots to standard care. Participants receive monthly injections and tests during their third tri…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Massive trial aims to slash infection risk in hip and knee replacements
Prevention Recruiting nowThis study tests if using antiseptic washes and placing antibiotics directly into the wound during hip or knee replacement surgery can lower the chance of a serious infection that requires another operation. Over 21,000 adults getting a joint replacement will be randomly assigned…
Phase: PHASE3 • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New vaccine aims to shield infants from pneumonia
Prevention Recruiting nowThis study tests a new vaccine (PCV21) designed to protect babies against 21 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 2,200 healthy infants will receive four doses of either the new vaccine or an existing one starting at 2 mont…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
New Two-Drug combo aims to stop leprosy spread in its tracks
Prevention Recruiting nowThis phase 3 trial tests whether a combination of two antibiotics (bedaquiline and rifampicin) can better prevent leprosy than the current standard single dose of rifampicin. Over 124,000 people living near a leprosy patient in the Comoros will receive either the new two-dose reg…
Phase: PHASE3 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Could a single pill stop lyme disease before it starts?
Prevention Recruiting nowThis study tests a new pill called TP-05 (lotilaner) to see if it can prevent Lyme disease in healthy adults who are often around ticks. The pill is already used in pets to kill ticks. Researchers will give either a low dose, high dose, or placebo to 700 volunteers and watch for …
Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Could a single friendly gut bacterium prevent recurrent c. diff?
Prevention Recruiting nowThis study tests EXL01, a single strain of a beneficial gut bacterium (Faecalibacterium prausnitzii), to see if it can prevent repeat Clostridioides difficile infections in people at high risk. About 56 adults who have had at least two C. diff episodes will take EXL01 or a placeb…
Phase: PHASE1, PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
Antibiotic shield: doxycycline may stop STIs in young women
Prevention Recruiting nowThis study tests whether taking the antibiotic doxycycline can prevent bacterial sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in adolescent and young adult females. About 760 participants aged 13-29 who have had an STI in the past year and recent…
Phase: PHASE4 • Sponsor: Westat • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Shorter TB prevention regimens put to the test in major trial
Prevention Recruiting nowThis study aims to find a shorter, safer treatment for latent tuberculosis (TB) infection to prevent it from becoming active disease. About 1800 adults and children with a positive TB test will try one of several daily pill regimens lasting 1 to 4 months. The goal is to identify …
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Love and safety: new study tests if relationship skills can cut HIV risk
Prevention Recruiting nowThis study tests an online program called all2GETHER that teaches relationship and communication skills to gay, bisexual, and queer men, as well as transgender and non-binary people who partner with cisgender men. The goal is to see if the program can lower HIV and STI rates. 5,0…
Phase: NA • Sponsor: Northwestern University • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
New pill aims to stop hearing loss from lifesaving antibiotics
Prevention Recruiting nowThis study tests whether the drug ORC-13661 can prevent hearing loss in people receiving intravenous amikacin for a lung infection called NTM. About 105 adults will take either a high dose, low dose, or placebo daily for up to 90 days. Researchers will compare hearing changes amo…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
TB prevention breakthrough? 6-Week regimen could replace months of treatment
Prevention Recruiting nowThis study compares a new 6-week daily rifapentine regimen to the standard 12-16 week rifamycin-based treatment for latent tuberculosis infection (LTBI). The goal is to see if the shorter treatment is just as safe and effective at preventing active TB. About 3,400 people at highe…
Phase: PHASE2, PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Home HIV tests and PrEP during TB checks could boost prevention
Prevention Recruiting nowThis study in Uganda tests whether offering HIV self-testing and PrEP (a daily pill to prevent HIV) at home during routine TB contact tracing can increase HIV prevention. About 2,480 people from households with a TB patient will be randomly assigned to either home-based HIV testi…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Simple handwashing program could curb cholera outbreaks
Prevention Recruiting nowThis study tests a program called CHoBI7, which teaches handwashing, water treatment, and safe water storage to diarrhea patients and their families in Bangladesh hospitals. Researchers want to see if this program reduces diarrhea and improves hygiene behaviors compared to standa…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Farming program aims to cut STI rates in kenyan teens
Prevention Recruiting nowThis study tests a program called Shamba Maisha that provides farming tools, training, and school gardens to families in Kenya. The goal is to reduce food insecurity and poverty, which are linked to higher STI and HIV risk in adolescent girls. Researchers will follow 900 girls an…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Finger sensor may prevent deadly skin failure in elderly ICU patients
Prevention Recruiting nowThis study tests whether using a device that measures blood flow to the skin (called the peripheral perfusion index) can help doctors give fluids more precisely to elderly ICU patients with sepsis or shock. The goal is to prevent acute skin failure, a serious condition where the …
Phase: NA • Sponsor: Ying Wang • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Rio study tests antibiotic after sex to stop STIs
Prevention Recruiting nowThis study tests whether taking the antibiotic doxycycline shortly after sex can prevent bacterial STIs like syphilis, gonorrhea, and chlamydia. It involves 200 men, transgender women, and travestis in Rio de Janeiro who are at higher risk. Participants choose whether to use doxy…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Kangaroo care could slash sepsis risk in tiny newborns
Prevention Recruiting nowThis study tests whether increasing kangaroo care (skin-to-skin contact) in neonatal intensive care units can reduce severe infections and antibiotic-resistant bacteria in very premature infants (born before 32 weeks). Over 3,000 babies across multiple hospitals will be involved.…
Phase: NA • Sponsor: PENTA Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Hospital trial aims to stop deadly c. diff before it starts
Prevention Recruiting nowThis trial tests a prevention bundle for hospital patients who carry C. difficile bacteria but have no symptoms. The bundle includes enhanced room cleaning and special precautions. Researchers hope to prevent these carriers from developing active infections and spreading the bact…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
Which hand rub saves more tiny lives? new trial aims to find out
Prevention Recruiting nowThis study compares two common hand rubs—chlorhexidine and alcohol—used by medical staff before touching premature babies in the NICU. The goal is to see which one better prevents healthcare-associated infections. One hundred premature infants will be monitored with blood culture…
Phase: NA • Sponsor: Alexandria University • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Could a malaria vaccine ward off another deadly disease?
Prevention Recruiting nowThis study looks at whether the R21/Matrix-M malaria vaccine can also reduce the risk of invasive non-typhoidal Salmonella (iNTS), a serious bacterial infection. Researchers will follow 10,000 children under 5 in the Democratic Republic of Congo who come to health centers with fe…
Sponsor: International Vaccine Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
New drug aims to stop dangerous gut infection from returning
Prevention Recruiting nowThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infection from coming back after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more pe…
Phase: PHASE2, PHASE3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Could a single antibiotic dose after sex stop STIs?
Prevention Recruiting nowThis study tests whether taking a single 200 mg dose of doxycycline within 24–72 hours after unprotected sex can prevent gonorrhea, chlamydia, and syphilis in men who have sex with men. Researchers in Bangkok will enroll 400 participants and follow them for 12 weeks. If effective…
Phase: PHASE4 • Sponsor: Bangrak STIs Center • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
Could a steroid injection make root canals less painful?
Symptom relief Recruiting nowThis study tests whether injecting the steroid dexamethasone near the tooth ligament or under the gum helps numb the tooth better and reduces pain during root canal treatment. It includes 84 adults with severe, irreversible pulpitis in a lower molar. Participants receive one of t…
Phase: NA • Sponsor: Marmara University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can saltwater breathing ease a tough lung infection?
Symptom relief Recruiting nowThis study tests whether inhaling a salty mist (3% hypertonic saline) can improve breathing symptoms in people with nontuberculous mycobacterial (NTM) lung disease who haven't yet started antibiotics. About 262 adults will either start the saltwater treatment right away for 6 mon…
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New dental shot may ease pain for kids with toothaches
Symptom relief Recruiting nowThis study tests whether a specially prepared (buffered) numbing shot works better than the standard shot to reduce pain and anxiety in children aged 6 to 12 who need a tooth filling or root canal for an infected baby tooth. Researchers will measure pain using a behavior scale, h…
Phase: NA • Sponsor: Universidad Autonoma de San Luis Potosí • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New tool helps pharmacists decide when antibiotics are needed for bladder infections
Symptom relief Recruiting nowThis study tests whether a shared decision-making tool can help pharmacists and patients better understand when antibiotics are truly needed for uncomplicated cystitis (bladder infection). About 506 women with symptoms will be enrolled. The goal is to reduce unnecessary antibioti…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New dental numbing method could spare kids from needle pain
Symptom relief Recruiting nowThis study compares two methods of numbing the lower back teeth in children who need emergency dental treatment. One method is a standard injection near the jaw nerve, and the other uses a computer-controlled device to deliver numbing medicine directly into the tooth area. Resear…
Phase: NA • Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New study seeks best way to save painful teeth without root canal
Symptom relief Recruiting nowThis study tests three treatments for teeth with deep cavities and severe, constant pain: total pulpotomy, radicular pulpotomy, and standard root canal. About 99 adults will receive one of these procedures, and their pain and healing will be tracked for a year. The goal is to fin…
Phase: NA • Sponsor: Mustafa Kemal University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New sedation cocktail may protect elderly hearts during ICU breathing support
Symptom relief Recruiting nowThis study compares two sedation methods for elderly ICU patients (65+) who need a breathing tube. One group gets a mix of propofol and ketamine, the other gets propofol alone. The goal is to see which causes fewer dangerous drops in blood pressure. The trial involves 41 particip…
Phase: PHASE3 • Sponsor: Helwan University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Could a single daily dose beat a double for lung infection treatment?
Symptom relief Recruiting nowThis study tests whether giving medication once a day through a chest tube works as well as giving it twice a day for people with serious infections around the lungs. Participants are adults already in the hospital with a chest tube draining infected fluid. They will be randomly …
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New pump lets kids get antibiotics at home, not hospital
Symptom relief Recruiting nowThis study tests whether giving antibiotics through a small, portable pump over 24 hours is safe and cost-effective for children with serious bacterial infections. About 150 kids who are stable enough for home care will receive the pump instead of multiple daily hospital injectio…
Phase: PHASE3 • Sponsor: Tampere University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a tiny ear zap ease Long-Term lyme symptoms?
Symptom relief Recruiting nowThis study tests a small, non-invasive device that gently stimulates a nerve in the ear (taVNS) to see if it is safe and tolerable for people with persistent symptoms after Lyme disease treatment. The trial will enroll 24 adults who still have symptoms like fatigue or pain months…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Zapping brain fog: new study tests tDCS for Lyme-Related memory issues
Symptom relief Recruiting nowThis study tests a new way to treat brain fog in people with post-treatment Lyme disease. Participants will play computer-based thinking games at home while receiving either real or fake brain stimulation (tDCS) for 4 weeks. Researchers will check if the active stimulation improv…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Catheter cleaning showdown: betadine vs sterile water – which is better?
Symptom relief Recruiting nowThis study compares two ways to clean the area before placing a temporary bladder catheter: Betadine (the current standard) versus sterile water. Researchers want to see if sterile water leads to fewer bacteria in the urine and less pain during the procedure. About 148 adults who…
Phase: PHASE4 • Sponsor: University of Louisville • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Antibiotics or sugar pill? new study questions need for drugs in Kids' pneumonia
Symptom relief Recruiting nowThis study looks at whether children with pneumonia caused by Mycoplasma bacteria need antibiotics to get better. About 376 children aged 3-17 will receive either a placebo (inactive pill) or a common antibiotic. Researchers will track how long symptoms like fever and fast breath…
Phase: NA • Sponsor: Christoph Berger • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Spa treatment shows promise for chronic kidney and urinary conditions
Symptom relief Recruiting nowThis study is testing whether a 21-day spa program—including mineral water baths, exercise, and diet—can improve kidney function and reduce symptoms in 150 adults aged 40-70 with chronic kidney or urinary tract diseases. Participants receive standard spa care at a resort in the C…
Phase: NA • Sponsor: Institute of Spa and Balneology, public research institution • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could an extra shot after a root canal cut pain and pill use?
Symptom relief Recruiting nowThis study tests whether giving patients an extra injection of a long-acting anesthetic (bupivacaine with epinephrine) right after a root canal can lower pain, improve quality of life, and reduce the need for painkillers. About 150 adults with tooth pain will be randomly assigned…
Phase: PHASE2 • Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Ice before the needle: simple trick to beat root canal pain?
Symptom relief Recruiting nowThis study tests whether placing an ice pack on the gum for 5 minutes before a numbing injection can improve pain control during root canal treatment. It involves 98 adults with severe, irreversible tooth nerve pain. The goal is to see if this simple cold therapy reduces the need…
Phase: PHASE4 • Sponsor: Ondokuz Mayıs University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New program aims to help HIV/TB patients kick the habit
Symptom relief Recruiting nowThis study is testing a new program called QUIT-AD to help people living with HIV or tuberculosis (TB) in Cape Town, South Africa, quit smoking. The program combines proven methods to support smoking cessation and improve HIV/TB treatment results. Researchers will enroll 86 daily…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Exercise program aims to boost fitness in rare lung infection
Symptom relief Recruiting nowThis study tests whether a 6-week exercise program can improve fitness and quality of life in people with nontuberculous mycobacterial pulmonary disease (NTM-PD), a chronic lung infection. Researchers will enroll 50 adults aged 40-80 and randomly assign them to start exercise rig…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Shower power: standing to pee may cut pain and catheter returns after surgery
Symptom relief Recruiting nowThis study looks at whether standing in the shower instead of sitting on the toilet helps women urinate more easily after having a catheter removed following vaginal surgery. The goal is to see if this position reduces pain, lowers the amount of urine left in the bladder, and dec…
Phase: NA • Sponsor: Assuta Ashdod Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Balloon blowing may ease breathing in children with tuberculosis
Symptom relief Recruiting nowThis study tests whether adding balloon blowing to standard breathing exercises helps children with tuberculosis cough up mucus, reduce shortness of breath, and improve their ability to walk. Thirty-four children aged 8 to 14 will be randomly assigned to either breathing exercise…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Dentists test two materials to save painful teeth without root canals
Symptom relief Recruiting nowThis study tests two materials, MTA and Biodentine, for treating a painful tooth condition called irreversible pulpitis. 60 adults with severe tooth pain will get a pulpotomy (removing infected pulp) and one of the materials. They will be followed for 3 months to see which materi…
Phase: NA • Sponsor: Dow University of Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Earthworm enzyme trial aims to ease long covid and chronic fatigue
Symptom relief Recruiting nowThis study tests a dietary supplement called lumbrokinase in 120 adults with Long Covid, post-treatment Lyme disease syndrome, or ME/CFS. Participants take the supplement daily for 6 weeks. The goal is to see if it improves overall health and quality of life, as measured by a sim…
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Calmer Wake-Ups for kids after eye surgery: which anesthesia dose works best?
Symptom relief Recruiting nowThis study tests whether a lower dose (6%) or a higher dose (8%) of sevoflurane gas works better and causes fewer side effects when putting children aged 1 to 6 years to sleep for minor eye surgery. The main goal is to see which dose leads to less agitation and confusion when the…
Phase: NA • Sponsor: Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New drug combo aims to prevent oxygen drops during lung scope procedures
Symptom relief Recruiting nowThis study tests whether adding remimazolam to standard sedation (propofol and alfentanil) can lower the risk of low oxygen levels in high-risk patients during painless tracheoscopy. About 360 participants with serious health conditions (ASA class 3-4) will be randomly assigned t…
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Flushing chest tubes may speed recovery from serious lung infections
Symptom relief Recruiting nowThis study looks at whether regularly flushing chest drains with salt water helps keep them from getting blocked in people with serious lung infections (empyema). The goal is to see if this simple step can shorten the time the drain needs to stay in, reduce hospital stays, and im…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Which root canal filler hurts less? new study aims to find out
Symptom relief Recruiting nowThis study looks at two types of dental sealers used in root canals to see which one causes less pain afterward. About 50 adults with tooth pain will get one of the two sealers and report their pain for three days. The goal is to help dentists choose the sealer that makes root ca…
Phase: NA • Sponsor: HITEC-Institute of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Bright blue light may tame inflammation in severe infections
Symptom relief Recruiting nowThis study tests whether exposure to bright blue light can reduce inflammation and organ damage in people hospitalized with serious infections like pneumonia, infected joints, or abdominal infections. Participants will be randomly assigned to receive either blue-enriched light or…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New root canal technique could mean less pain for patients
Symptom relief Recruiting nowThis study tests a new way to do root canals that skips the manual step of scouting and widening the canal by hand. Instead, dentists use a special rotary file from the start. The goal is to see if this causes less pain after the procedure compared to the traditional method. The …
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Tonsils shed light on staph Bacteria's secrets
Knowledge-focused Recruiting nowThis study aims to understand how Staphylococcus aureus bacteria interact with human cells to cause infections, especially in the spine. Researchers will use tonsil tissue discarded after routine tonsillectomies to create lab models. About 500 participants aged 2 and older who ar…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 03, 2026 23:00 UTC
-
Lyme disease mystery: do bacteria lurk after antibiotics?
Knowledge-focused Recruiting nowThis study investigates whether the bacteria causing Lyme disease can survive antibiotic treatment and cause ongoing symptoms. Researchers will follow 700 participants, including those with chronic Lyme disease, recovered individuals, and healthy volunteers, using blood tests, sp…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 03, 2026 23:00 UTC
-
Aging immune system under the microscope: study seeks clues to infection risk in seniors
Knowledge-focused Recruiting nowThis study looks at how the immune system changes with age and how that affects the risk of infections in people 60 and older. Researchers will collect blood, urine, stool, and other samples from elderly patients with infections and healthy older adults. By analyzing immune cells…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple kidney test help beat superbugs in the ICU?
Knowledge-focused Recruiting nowThis study aims to see if using a blood marker called Cystatin C can better predict how antibiotics work in critically ill ICU patients with drug-resistant infections. Researchers will compare Cystatin C to standard kidney function tests and a dye-based gold-standard test. The go…
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Can a rapid test help doctors pick the right antibiotic faster?
Knowledge-focused Recruiting nowThis study tests whether a rapid lab test can help doctors choose the right antibiotic sooner for patients with bloodstream infections. About 400 adults with positive blood cultures will be randomly assigned to either the rapid test or standard testing. The goal is to see if the …
Phase: NA • Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists launch major study to unravel mysteries of rare lung infections
Knowledge-focused Recruiting nowThis study aims to learn more about non-tuberculous mycobacterial (NTM) infections, which cause repeated lung and other organ infections. Researchers will study up to 1,000 participants to understand the genetics, symptoms, and best treatments for these infections. The study also…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could bile acids explain why kids with colitis get more c. diff infections?
Knowledge-focused Recruiting nowThis study looks at bile acid profiles in children with ulcerative colitis (UC) who also have a C. difficile infection. Researchers want to see if changes in bile acids and gut bacteria make these children more vulnerable. They will compare three groups: children with UC flare-up…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Lyme disease and parenthood: a hidden struggle revealed
Knowledge-focused Recruiting nowThis study explores the real-life experiences of people who had Lyme disease during or before pregnancy and are now raising children. Participants fill out surveys about their health, mental well-being, and child development, then take part in an interview to share their personal…
Sponsor: Children's National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood protein clues could predict sepsis in cancer patients
Knowledge-focused Recruiting nowThis study looks at blood samples from 350 adults with blood cancer who develop a fever and have very low white blood cells (a condition called febrile neutropenia). The goal is to find patterns of proteins in the blood that can predict if a patient will develop serious complicat…
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
NIH launches study to better handle bioterrorism and outbreak exposures
Knowledge-focused Recruiting nowThis study aims to improve how doctors evaluate and manage people who have been exposed to bioterrorism agents (like anthrax) or emerging infectious diseases (like SARS or new flu strains). Up to 200 participants, including patients and healthcare workers, will be monitored and t…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Lyme disease in pregnancy: new study tracks baby brain development
Knowledge-focused Recruiting nowThis study follows 40 pregnant women with Lyme disease to see how the infection might affect their baby's development. Researchers will monitor pregnancies and check infant growth, thinking, and motor skills from birth to 18 months. The goal is to learn if Lyme exposure in the wo…
Sponsor: Children's National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple CO2 test save lives in septic shock?
Knowledge-focused Recruiting nowThis study compares two methods for guiding early treatment in people with septic shock, a severe infection that can cause organ failure. The standard approach uses blood lactate levels, but this trial tests whether using the CO2 gap (a measure of blood flow) is better at reducin…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Which works better: one antibiotic or two for this superbug?
Knowledge-focused Recruiting nowThis study looks at 790 adults with S. maltophilia infections, a hard-to-treat bacteria. Researchers will compare patients who got one antibiotic versus those who got a combination, to see which group has fewer deaths within 30 days. The goal is to find the best treatment approac…
Sponsor: Instituto de Investigación Sanitaria Gregorio Marañón • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a stool test predict c. Diff's return?
Knowledge-focused Recruiting nowThis study follows 60 adults who have had a C. diff infection return after standard antibiotic treatment. Researchers want to see how often the infection comes back within 8 weeks and whether measuring toxin levels in stool can predict that risk. Participants provide stool sample…
Sponsor: Bactolife A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood marker may predict lung disease worsening in NTM patients
Knowledge-focused Recruiting nowThis study looks at whether a substance in the blood called soluble PD-1 can help predict if a certain type of lung disease caused by NTM bacteria will get worse. Researchers will follow 500 adults from different countries to see if higher levels of this marker are linked to more…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Can a skin biopsy tell your doctor which treatment will work?
Knowledge-focused Recruiting nowThis study is collecting skin and blood samples from 830 people with chronic inflammatory skin diseases like psoriasis, eczema, and lupus. Researchers want to find biological markers that can predict how well a person will respond to treatment after one year. The goal is to move …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
New study tracks infection risks in patients with large leg implants
Knowledge-focused Recruiting nowThis study is observing 200 patients who received a large leg implant (megaprosthesis) between 2020 and 2023. Researchers want to learn how many get infections, what puts them at risk, and how those infections turn out. The goal is to gather information, not to test a new treatme…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Emergency UTI treatment under review: study aims to cut unnecessary antibiotic use
Knowledge-focused Recruiting nowThis study looks at how doctors can improve antibiotic prescriptions for urinary tract infections (UTIs) after patients leave the emergency department. Researchers will check if adjusting antibiotics based on lab test results reduces the use of strong drugs like fluoroquinolones.…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New french TB study aims to improve treatment success
Knowledge-focused Recruiting nowThis study will follow 2000 adults in France who are starting treatment for tuberculosis. Researchers will collect health data and samples like blood, urine, and breath over two years to see how well treatments work. The goal is to learn more about TB care and build a biobank for…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Scientists seek best dose of Last-Resort antibiotics for superbug infections
Knowledge-focused Recruiting nowThis observational study is looking at how two antibiotics, ceftazidime/avibactam and fosfomycin, work in the body to treat infections caused by carbapenem-resistant Enterobacterales (CRE), a type of superbug. Researchers will monitor 60 adult patients to see if the drug levels i…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists probe immune secrets of tuberculosis to find better treatments
Knowledge-focused Recruiting nowThis study looks at how different types of mycobacterial infections, including drug-resistant tuberculosis and nontuberculous mycobacteria, change the body's immune response. Researchers will collect blood and other samples from 120 participants, including healthy people and thos…
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New rapid test could speed up sepsis diagnosis in ER
Knowledge-focused Recruiting nowThis study is testing a new rapid diagnostic device called In-Dx to quickly identify infections and antibiotic resistance in emergency patients with suspected sepsis. Researchers will compare the device's results to standard lab cultures using stored samples from 2,500 patients. …
Sponsor: Michigan State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Teens' sleep habits may boost vaccine power
Knowledge-focused Recruiting nowThis study looks at whether sleep habits of 11-12 year olds affect their immune response to the meningococcal vaccine (MCV4). About 66 healthy teens will wear a sleep tracker and keep their normal sleep schedule for 5 weeks. Researchers will measure antibody levels after vaccinat…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Charcoal filters in cigarettes: safer or just a marketing gimmick?
Knowledge-focused Recruiting nowThis study looks at whether charcoal-filtered cigarettes change how people smoke and how much harmful chemicals they breathe in. About 252 adult smokers who smoke at least 5 cigarettes a day will be randomly assigned to smoke either charcoal-filtered or regular cigarettes for 4 w…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Anthrax secrets revealed: new study tracks infection and vaccine response
Knowledge-focused Recruiting nowThis study follows people who have or had anthrax, those exposed, and healthy vaccinated volunteers to learn how the body fights the disease. Researchers will track symptoms, immune responses, and long-term health for up to 2 years. The goal is to better understand anthrax and im…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Stomach acid drugs may skew h. pylori stool test results
Knowledge-focused Recruiting nowThis study looks at whether taking common acid-reducing drugs (proton pump inhibitors, or PPIs) affects the accuracy of a stool DNA test for H. pylori, a stomach bacteria. Researchers will test 25 adults who need PPIs, first while on the drug and then after stopping it for 4 week…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
CF breakthrough may lower antibiotic doses, reduce side effects
Knowledge-focused Recruiting nowThis study looks at how the cystic fibrosis drug ETI affects the way the body handles antibiotics. Researchers want to see if people on ETI need lower antibiotic doses to treat lung infections, which could reduce harmful side effects like hearing loss or kidney damage. The study …
Sponsor: Fondation Ildys • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
NIH launches major lyme disease observation study to uncover hidden clues
Knowledge-focused Recruiting nowThis study follows 500 people with active Lyme disease to learn more about the infection. Participants receive standard FDA-approved treatments and undergo tests like blood draws and leukapheresis. The goal is to explore biological markers, track clinical outcomes, and understand…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
5 years later: does one meningitis shot still shield?
Knowledge-focused Recruiting nowThis study looks at how well the MenFive (NmCV-5) meningitis vaccine still works more than five years after a single shot. Researchers will test the blood of 450 people in Mali and The Gambia who got the vaccine when they were 2 to 29 years old. The goal is to see if their immune…
Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Hotspot vs clinic: which TB hunt saves more lives?
Knowledge-focused Recruiting nowThis study compares two strategies for finding undiagnosed tuberculosis (TB) in peri-urban Uganda. One strategy sets up screening at a large health clinic, while the other sends mobile screening teams into local hotspots where TB is thought to be most common. Researchers will tra…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Tiny molecules may hold key to septic shock immune failure
Knowledge-focused Recruiting nowThis study looks at small molecules called miRNAs in the blood of patients with septic shock. The goal is to understand why some patients develop a weakened immune system after sepsis, which can lead to more infections and higher risk of death. Researchers will compare miRNA patt…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Why your dental numbing shot might not work: gene and inflammation clues
Knowledge-focused Recruiting nowThis study examines why some people with a painful tooth infection (irreversible pulpitis) don't get fully numb from a standard dental injection. Researchers will measure levels of certain genes and inflammatory markers in the tooth pulp to see if they predict anesthesia success.…
Sponsor: Jamia Millia Islamia • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study of deceased ICU patients aims to prevent future deaths from joint infections
Knowledge-focused Recruiting nowThis study looks back at the medical records of 150 patients who died in intensive care between 2018 and 2022 after being treated for a joint prosthesis infection. The goal is to understand what went wrong and identify patterns that could help doctors better manage similar cases …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can we better predict tetanus death risk?
Knowledge-focused Recruiting nowThis study looks at three different scoring systems to see which one best predicts the risk of death in patients with severe tetanus in the intensive care unit. Researchers will follow 115 adults with tetanus for up to 90 days. The goal is to find the most accurate tool to help d…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Could personalized antibiotic dosing save lives in liver cirrhosis?
Knowledge-focused Recruiting nowThis study is observing 1,000 people with liver cirrhosis who have bacterial infections and are being treated with β-lactam antibiotics. Researchers want to see how the body processes these drugs and whether personalized dosing could improve survival. The study is observational, …
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Hospitals team up to solve mystery of Hard-to-Treat lung infections
Knowledge-focused Recruiting nowThis study helps U.S. healthcare centers figure out if patients are getting NTM lung infections from the hospital environment. Researchers will compare germs from patients' lungs with germs from water and dust in the hospital and homes. The goal is to create a standard method to …
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Heart-Lung link may predict sepsis survival
Knowledge-focused Recruiting nowThis study looks at whether a simple ultrasound measurement of how well the right side of the heart works with the lungs can predict which sepsis patients are at higher risk of dying in the hospital. Researchers will follow 215 adults with sepsis in the ICU, measuring this heart-…
Sponsor: University Medical Center Ho Chi Minh City (UMC) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New sensor could replace painful finger pricks for ICU patients
Knowledge-focused Recruiting nowThis study is testing whether a continuous glucose monitor (CGM) designed for diabetes can work in intensive care patients with septic shock. Currently, nurses must prick patients' fingers every 2 hours to check blood sugar, which is painful and disruptive. The CGM uses a small s…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New antibiotic under the microscope: can it beat superbug infections?
Knowledge-focused Recruiting nowThis study is observing 200 hospitalized adults with carbapenem-resistant Acinetobacter baumannii (CRAB) infections—a type of superbug—who are treated with the antibiotic sulbactam-durlobactam. Researchers will compare their outcomes to patients receiving other treatments to see …
Sponsor: Sichuan Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Groundwork laid for lifesaving GBS vaccine trials in africa
Knowledge-focused Recruiting nowThis study prepares medical sites in Kenya, Malawi, Mozambique, and Uganda for future trials of a vaccine against Group B Streptococcus (GBS), a leading cause of serious infections in newborns. Researchers will track pregnancy and infant health data and monitor GBS cases in babie…
Sponsor: Barcelona Institute for Global Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Pee power: urine test could unlock chlamydia immunity secrets
Knowledge-focused Recruiting nowThis study looks at whether urine samples can show immune markers of chlamydia infection in women. Participants provide urine, vaginal, and blood samples to compare immune responses. The goal is to find easier ways to study chlamydia immunity, which could help develop better test…
Sponsor: Universiteit Antwerpen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Cortisol levels may predict sepsis outcomes in ICU
Knowledge-focused Recruiting nowThis study is measuring cortisol levels in 183 adults with sepsis or septic shock in the ICU to see if those levels can predict who is at higher risk of dying. Researchers will track deaths in the ICU and at 28 and 90 days. The goal is to help doctors identify high-risk patients …
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Study aims to uncover hidden health differences in rare lung infections
Knowledge-focused Recruiting nowThis study looks at 80 adults—40 with NTM lung disease (not on antibiotics) and 40 with bronchiectasis alone—to see if their health needs differ. Using questionnaires and simple physical tests, researchers will assess quality of life, nutrition, mood, and muscle strength. The goa…
Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Gene sleuths hunt down the true source of blood infections in hospitalized kids
Knowledge-focused Recruiting nowThis study aims to figure out where bloodstream infections in children with central lines actually come from. By comparing the DNA of bacteria from the blood with bacteria from the gut, mouth, and skin, researchers hope to tell whether the infection started from the line itself o…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Scientists launch major study to unlock secrets of respiratory infections
Knowledge-focused Recruiting nowThis study aims to collect blood and saliva samples from 2000 adults who come to the emergency room with a suspected respiratory infection. Researchers will use these samples to better understand how the body responds to infections and to find new ways to diagnose and treat them.…
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Frailty score may reveal hidden risks for young septic shock patients
Knowledge-focused Recruiting nowThis study looks at whether frailty—measured by a simple scale—can predict death in adults aged 18 to 65 admitted to intensive care for septic shock. Researchers will track 200 patients to see if those who are frail have a higher risk of dying within 28 days, even after accountin…
Sponsor: Centre Hospitalier de Lens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Massive meningitis study aims to improve care in brazil
Knowledge-focused Recruiting nowThis study is tracking how adults with meningitis are treated in about 30 hospitals across Brazil. Researchers will follow 624 patients during their hospital stay and after discharge to see what treatments work best and how patients recover. The goal is to gather real-world evide…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a new score better predict ICU deaths? turkish study aims to find out
Knowledge-focused Recruiting nowThis study will check if a new scoring system called SOFA-2 can better predict which ICU patients are likely to die within 30 days, compared to the current standard. Researchers will also measure how common sepsis and septic shock are in Turkish intensive care units. About 2,500 …
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
15-Year study aims to uncover hidden death risks in intestinal TB patients
Knowledge-focused Recruiting nowThis study looks back at 15 years of medical records and will also follow new patients with intestinal tuberculosis to find out which factors—like age, other illnesses, or treatment habits—make death more likely. Researchers will collect data from 500 adults diagnosed with intest…
Sponsor: Beijing Chest Hospital, Capital Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Cash for health: study tests if money can boost TB screening in poor, rural areas
Knowledge-focused Recruiting nowThis study tests whether offering a small cash payment to households can encourage more people to get screened for tuberculosis (TB) in rural Tanzania. Researchers will enroll 360 people recently diagnosed with TB and their families. Half will receive the usual care, and half wil…
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New registry aims to improve meningitis treatment for kids
Knowledge-focused Recruiting nowThis study is creating a registry of 600 children under 18 with meningitis treated at hospitals across Brazil. Researchers will collect data during and after hospitalization to see how well current treatments work and what long-term problems, like hearing loss, occur. The goal is…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Quick STI tests may boost HIV prevention in teens
Knowledge-focused Recruiting nowThis study tests whether offering rapid point-of-care testing for gonorrhea and chlamydia helps more teens get HIV testing and PrEP. About 6,460 adolescents aged 16-24 will be compared: some get rapid testing, others get standard lab testing. The goal is to see if same-day result…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists probe lung microbiome to unlock TB secrets
Knowledge-focused Recruiting nowThis study looks at the bacteria living in the lungs of people with active tuberculosis (TB) and how they change with treatment. Researchers will compare lung bacteria in diseased and healthy areas, and also check the mouth, nose, and gut. They aim to understand how these microbe…
Sponsor: University of Stellenbosch • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists expose volunteers to tick bites to unlock vaccine secrets
Knowledge-focused Recruiting nowThis study looks at how healthy people's skin and immune system respond to tick bites. Researchers will place clean, lab-bred ticks on volunteers' skin and take small skin samples and blood to track changes. The goal is to understand tick resistance and help design future vaccine…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Web lessons aim to boost vaccine knowledge in pregnant women
Knowledge-focused Recruiting nowThis study tests whether a web-based educational program can improve pregnant women's knowledge about influenza and Tdap vaccines and increase their intention to get vaccinated. Researchers will compare the program to standard antenatal care in 351 pregnant women in Malaysia. Par…
Phase: NA • Sponsor: Universiti Putra Malaysia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Blood samples from vaccinated moms could help perfect GBS protection for newborns
Knowledge-focused Recruiting nowThis study collects blood from 50 women in Uganda who previously received an experimental group B strep (GBS) vaccine during pregnancy. The blood is used to create quality control panels that help labs accurately measure vaccine-induced antibodies. The goal is to improve testing …
Sponsor: St George's, University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
TB treatment mystery: why do some patients suddenly worsen?
Knowledge-focused Recruiting nowThis study aims to understand why some people with tuberculosis (TB) experience a paradoxical reaction, where they initially improve on treatment but then suddenly get worse. Researchers will follow 140 adults with TB, with or without signs of this reaction, using blood tests, ur…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Researchers track Real-World treatment of serious ENT infections
Knowledge-focused Recruiting nowThis study is observing how doctors manage complicated infections of the ears, nose, throat, and neck in both children and adults. Researchers will track standard treatments like surgery or medication to understand current practices. No new treatments are being tested; the goal i…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Mind over lyme: do expectations shape recovery?
Knowledge-focused Recruiting nowThis study looks at whether what patients expect before treatment for early Lyme disease (a red rash called erythema migrans) influences how well they recover. Researchers will follow 200 patients for up to a year, checking for lingering symptoms and comparing them to healthy peo…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Massive study tracks meningitis trends in 10,000 kids
Knowledge-focused Recruiting nowThis study is a national observatory that will follow 10,000 children and newborns with bacterial meningitis. Researchers aim to understand which bacteria are causing infections, how often treatments fail, and how well vaccines are working. The goal is to improve future treatment…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New scoring system could save lives of pregnant women in ICU
Knowledge-focused Recruiting nowThis study aims to create a new scoring system (SOFA-OBS) that better predicts death risk for pregnant and postpartum women in intensive care. Researchers will collect routine data from 130 patients and test if a simple pulse oximeter can replace painful blood draws. The goal is …
Sponsor: Daniela Vasquez • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Brazil launches massive leprosy hunt: can active screening catch hidden cases?
Knowledge-focused Recruiting nowThis trial tests whether actively searching for leprosy cases in communities finds more people with the disease than waiting for them to come to clinics. Researchers will raise awareness, train healthcare workers, and use questionnaires and rapid tests in high-risk areas. About 1…
Phase: NA • Sponsor: Hospital Alemão Oswaldo Cruz • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
French study tracks pneumococcal infections in kids after vaccine rollout
Knowledge-focused Recruiting nowThis study is observing 2,500 children in France to understand how pneumococcal vaccines have changed the severity and types of pneumococcal infections. Researchers will look at which bacterial strains cause disease, how severe the infections are, and whether children were vaccin…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Ultrasound showdown: which method best guides fluid resuscitation in septic shock?
Knowledge-focused Recruiting nowThis study looks at two different ultrasound techniques to help doctors decide how much fluid to give patients with septic shock. One method measures the heart's left ventricle, while the other checks blood flow in the carotid artery. The goal is to see which is more accurate at …
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tooth decay study: do symptoms and cavity depth predict treatment success?
Knowledge-focused Recruiting nowThis study looks at how a patient's symptoms before treatment and how deep the cavity is affect the success of partial decay removal in adult teeth. One hundred adults with deep cavities will be treated and followed for 12-24 months. The goal is to see if these factors influence …
Sponsor: University of Helsinki • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny probe could give doctors a window into infant brains
Knowledge-focused Recruiting nowThis study tests a new, lightweight ultrasound device called NeoDoppler that can be gently placed on a newborn's soft spot (fontanelle) to continuously measure blood flow in the brain. Researchers will enroll 180 preterm and full-term infants, including those with conditions like…
Sponsor: St. Olavs Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Massive infection database aims to unlock secrets of deadly diseases
Knowledge-focused Recruiting nowThis study is creating a large registry and biobank of 10,000 adults with various infections, such as bloodstream, heart, and bone infections. Researchers will collect medical data and biological samples to describe the infections and their treatments. The goal is to better under…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Blood markers could spot sepsis risk early
Knowledge-focused Recruiting nowThis study is looking at whether early signs of inflammation in the blood can help identify which patients with infections are at risk for serious complications like sepsis. Researchers will follow 4,200 adults with confirmed or suspected infections, as well as healthy controls, …
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
ICU study checks if blood filters zap Life-Saving antibiotics
Knowledge-focused Recruiting nowThis study looks at how a blood-filtering cartridge (HA 380) used with continuous kidney dialysis removes antibiotics in ICU patients with septic shock and kidney failure. Researchers will take blood samples before and after the filter at several time points to measure changes in…
Sponsor: Niguarda Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Blue dye study aims to find the right washout volume for infected knee implants
Knowledge-focused Recruiting nowThis pilot study is testing how much irrigation fluid is needed to clear contaminants during revision knee replacement surgery for infection. Surgeons will apply a blue dye to the knee joint and wash it out in measured steps until the dye is gone. The goal is to gather data to de…
Phase: PHASE1 • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Why does Doxy-PEP fail some people? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at why the antibiotic doxycycline, when taken after sex, prevents bacterial STIs in some people but not others. Researchers will measure doxycycline levels in hair, blood, and urine from 48 volunteers to develop better ways to track if people are taking the medic…
Phase: EARLY_PHASE1 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
TB Patients' COVID-19 vaccine response under the microscope
Knowledge-focused Recruiting nowThis study compares the immune response to COVID-19 vaccines between people being treated for tuberculosis (TB) and healthy individuals. About 133 participants in the Thailand-Myanmar border area will receive one of three vaccines (Pfizer, AstraZeneca, or Janssen). Researchers wi…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood test could revolutionize TB treatment monitoring
Knowledge-focused Recruiting nowThis study explores whether measuring tiny DNA fragments from the TB bacteria in the blood can help doctors monitor how well treatment is working. Researchers will enroll 140 adults with newly diagnosed TB in Thailand, taking blood samples over time to see if the DNA levels drop …
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Tampon or cup? new study reveals hidden impact on Women's health
Knowledge-focused Recruiting nowThis study looks at how different menstrual products—tampons, cups, and pads—affect the bacteria and immune cells in the vagina. Researchers will collect samples from 300 women aged 18-49 to compare these groups. The goal is to understand if internal products like tampons and cup…
Sponsor: Centre National de la Recherche Scientifique, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Scientists hunt for cholera protection clues to speed up vaccines
Knowledge-focused Recruiting nowThis study looks for immune markers that show whether a person is protected from cholera after vaccination or natural infection. About 1,200 people will receive either a cholera vaccine or a typhoid vaccine (as a comparison) and give blood samples over two years. The goal is to f…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Massive study aims to crack the code on Kids' medications
Knowledge-focused Recruiting nowThis study is collecting blood and other samples from 5,000 children and young adults (under 21) who are already taking certain medications as part of their regular care. The goal is to understand how these drugs move through and affect children's bodies, so doctors can prescribe…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Heart infection survivors test rehab to boost recovery
Knowledge-focused Recruiting nowThis study looks at how people recover after infective endocarditis, a serious heart infection. Researchers want to see if a 12-week exercise program can improve physical fitness, fatigue, and quality of life. About 50 adults who had the infection will take surveys, do interviews…
Phase: NA • Sponsor: Region Halland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists hunt for genetic clues to severe infections in kids
Knowledge-focused Recruiting nowThis study aims to understand why some children develop severe bacterial infections that require intensive care. Researchers will analyze blood samples and medical histories from 1,401 children who were hospitalized for such infections between 2015 and 2018 in France. By comparin…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New guidelines aim to cut unnecessary antibiotics in febrile babies
Knowledge-focused Recruiting nowThis study looks at whether a new, simpler guideline can safely reduce the number of tests, antibiotics, and hospital stays for infants under 2 months old with a fever. Researchers will compare hospitals using the new guideline to those using standard care. The goal is to find ou…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Hidden syphilis: new study targets silent spread in women and straight men
Knowledge-focused Recruiting nowThis study aims to understand how syphilis bacteria spread from people without visible symptoms, focusing on women and men who have sex with women only—groups often overlooked in past research. Researchers will collect swabs and blood samples from 480 participants with early syph…
Sponsor: Monash University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Massive h. pylori study aims to find best treatment
Knowledge-focused Recruiting nowThis registry will follow 10,000 people in Shandong, China, who are being treated for H. pylori infection. Doctors will prescribe standard treatments based on guidelines, and researchers will track how well each treatment works and any side effects. The goal is to learn which str…
Sponsor: Yueyue Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Why vaccines may fail in older adults: new study investigates immune cell role
Knowledge-focused Recruiting nowThis study looks at how a type of immune cell called neutrophils affects the body's response to the pneumococcal vaccine in young (21-40) and older (65+) adults. Researchers will measure how well neutrophils kill pneumonia bacteria after vaccination. The goal is to understand why…
Phase: PHASE4 • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New blood ratio could predict septic shock survival
Knowledge-focused Recruiting nowThis study looks at whether a new blood gas ratio can help predict which patients with septic shock are more likely to survive. Researchers will measure this ratio and compare it to standard lactate levels in 30 adults with septic shock. The goal is to see if the ratio gives earl…
Sponsor: Avicenna Military Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New study tracks hidden infections in migrants
Knowledge-focused Recruiting nowThis study looks at how common certain infections are among 250 asylum seekers living in reception centers in Italy. Participants must be adults who arrived in Italy between 2 and 36 months ago. The goal is to better understand infection rates to improve health screening and care…
Phase: NA • Sponsor: IRCCS Sacro Cuore Don Calabria di Negrar • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
West indies stomach cancer study seeks hidden infection clues
Knowledge-focused Recruiting nowThis study looks at how common Helicobacter pylori infection is in people newly diagnosed with stomach cancer in Martinique. Researchers will collect tumor samples, healthy tissue, and blood to build a biobank. The goal is to understand why stomach cancer is more common in the We…
Sponsor: University Hospital Center of Martinique • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Toothache breakthrough: blood test may predict need for root canal
Knowledge-focused Recruiting nowThis study looks at whether substances in the blood from a decayed tooth can predict if a tooth-saving procedure called vital pulp treatment will succeed. Researchers will collect a small blood sample from the tooth during treatment and check for specific metabolic markers. They …
Phase: NA • Sponsor: Abeer Ghalib Abdul-khaliq • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Pregnant women needed for antibiotic safety study
Knowledge-focused Recruiting nowThis study looks at how two antibiotics, ceftriaxone and benzathine penicillin G, are processed by the body during pregnancy. Up to 78 pregnant women in the U.S. will take one of these drugs as part of their regular care, and researchers will measure drug levels in their blood. T…
Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Teens needed for First-Ever antibiotic safety study
Knowledge-focused Recruiting nowThis early-stage study is testing whether a single dose of an experimental antibiotic combination (sulopenem etzadroxil plus probenecid) is safe and tolerable in 12 adolescents already receiving standard antibiotics for a bacterial infection. Researchers will measure how the drug…
Phase: PHASE1 • Sponsor: Iterum Therapeutics, International Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Bladder microbiome study aims to unlock secrets of urinary diseases
Knowledge-focused Recruiting nowThis study from the University of Zurich is looking at how tiny organisms (microbes) and the immune system interact in the bladder. Researchers will collect samples from 800 adults with various urinary conditions, including infections, bladder pain, and overactive bladder, as wel…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Typhoid vaccine study seeks immune clues
Knowledge-focused Recruiting nowThis study gives healthy adults the licensed oral typhoid vaccine (Vivotif) and collects blood, saliva, and stool samples over up to eight years. Researchers want to learn how the vaccine triggers protective immune responses, which could help design better vaccines for typhoid an…
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Pharmacists may cut dangerous delays in blood infection alerts
Knowledge-focused Recruiting nowThis study looks at whether emergency medicine pharmacists can review positive blood culture results faster after patients leave the emergency department. Delays in notifying patients about serious infections can lead to sepsis or death. The trial will compare how quickly pharmac…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Peer power: uganda study tests if community counselors boost TB-HIV outcomes
Knowledge-focused Recruiting nowThis study in Uganda tests whether trained peer counselors can help people with tuberculosis (TB) and HIV stay on track with their medications. About 1,920 adults will take part, and researchers will compare treatment success rates between clinics using peer-led education and tho…
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Scientists probe why poop transplants work for gut infections
Knowledge-focused Recruiting nowThis study tracks how fecal microbiota transplantation (FMT) alters the gut microbiome in 20 adults with recurrent Clostridioides difficile infection. Researchers will analyze stool samples before and up to 90 days after FMT to see which bacteria take hold. The goal is to underst…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to spot warning signs of deadly infections in kids
Knowledge-focused Recruiting nowThis study will follow 3,000 children hospitalized with severe bacterial infections to understand what makes them so dangerous. Researchers will collect data on the bacteria, the children's health, and the care they receive. The goal is to find risk factors and early warning sign…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New blood tests could speed up sepsis detection
Knowledge-focused Recruiting nowThis study is observing about 1,950 emergency patients with suspected sepsis to see if new blood tests (like calprotectin and bacterial DNA tests) can detect infections faster and more accurately than current methods. The goal is to find better ways to diagnose sepsis and tailor …
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Scientists probe catheter biofilm to stop ICU blood infections
Knowledge-focused Recruiting nowThis study looks at the sticky layer (biofilm) that can form on arterial catheters in intensive care patients. About 60 adults in the ICU will have their catheters examined after removal to see what types of bacteria or fungi are present and how the biofilm is structured. The goa…
Sponsor: Centre Hospitalier William Morey - Chalon sur Saône • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Hip infection study aims to improve treatment choices
Knowledge-focused Recruiting nowThis study follows 50 adults with infected hip replacements treated at University Hospitals Leuven. Researchers will track which treatments (antibiotics or surgery) work best and note complications. The goal is to gather real-world data to help doctors and patients make better de…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New study aims to perfect antibiotic dosing for sickest kids
Knowledge-focused Recruiting nowThis study looks at how the antibiotic ceftazidime avibactam behaves in 30 children with severe infections who are in intensive care, some on life support. Researchers will measure drug levels in the blood to understand the right dose. The goal is to improve treatment for life-th…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Swiss study aims to crack the code on joint infection cures
Knowledge-focused Recruiting nowThis study follows 329 adults who need surgery for an infection after a hip, knee, or other joint replacement. Researchers will track which treatments—surgery and antibiotics—lead to the best outcomes. The goal is to find patterns that help cure infections more reliably and impro…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Burn patients needed for antibiotic dosing study
Knowledge-focused Recruiting nowThis study looks at how the antibiotic cefiderocol behaves in the bodies of people with severe burns. Researchers want to find the best dose to kill bacteria and prevent resistance. The study will enroll 12 adults with burns who have good kidney function.
Phase: PHASE4 • Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Hidden stomach germs found during routine colonoscopy in healthy adults
Knowledge-focused Recruiting nowThis study looks at how common Helicobacter pylori (a stomach germ linked to cancer) is in adults without stomach symptoms who are already getting a screening colonoscopy. About 1,000 participants will also have a stomach exam (gastroscopy) during the same visit, with small tissu…
Sponsor: Sigmund Freud PrivatUniversitat • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Which antibiotic wins against superbugs? new study aims to find out
Knowledge-focused Recruiting nowThis study compares two strong antibiotics, polymyxin B and colistin, in treating serious infections caused by bacteria that are resistant to many common drugs. Researchers will look at medical records of 480 adults with pneumonia or bloodstream infections to see which antibiotic…
Sponsor: TTY Biopharm • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
C. diff mystery: new study aims to unlock why infections keep coming back
Knowledge-focused Recruiting nowThis study follows 100 hospitalized patients with Clostridioides difficile infection to track how quickly the bacteria clears from the gut during and after standard antibiotic treatment. Researchers will also analyze gut bacteria and immune responses in stool samples to identify …
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Why do french dentists pull baby teeth? a new survey aims to find out
Knowledge-focused Recruiting nowThis study surveys 100 French dentists who treat children to understand why they often choose extraction for non-vital baby teeth, even though effective alternatives like pulpectomy exist. The goal is to collect and analyze their treatment choices, reservations, and decision-maki…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Scientists probe immune cells to unlock secrets of sarcoidosis and TB
Knowledge-focused Recruiting nowThis study looks at how certain immune cells (monocytes and macrophages) behave in sarcoidosis and tuberculosis. Researchers will compare blood and tissue samples from 100 adults to find patterns that explain why these cells stay overactive in sarcoidosis. The goal is to better u…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Knee replacement system under Long-Term review
Knowledge-focused Recruiting nowThis study looks at how well the Triathlon Hinge Knee System works in people who need knee replacement surgery, either for the first time or to fix a previous one. Researchers will follow about 200 patients for up to 10 years to see how long the implant lasts and how well patient…
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Scientists hunt for bacterial clues in Hard-to-Treat lung infection
Knowledge-focused Recruiting nowThis study looks at the bacteria living in the lungs of people with a chronic lung condition called bronchiectasis who may also have an NTM infection. Researchers will collect sputum and airway samples from 1000 participants to compare the lung microbiome of those with and withou…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Stomach bug subtypes may raise cancer risk – study to track 3,000 people
Knowledge-focused Recruiting nowThis study follows 3,000 adults aged 40 and older who carry Helicobacter pylori, a common stomach bug. Researchers want to see if people with certain high-risk subtypes of the bacteria develop stomach cancer more often than those with other subtypes or no infection. Participants …
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study tracks antifungal drug in sick kids
Knowledge-focused Recruiting nowThis study looks at how the antifungal medicine caspofungin behaves in children with severe infections, especially those with liver problems or on life support like ECMO. Researchers will measure drug levels in the blood to understand dosing needs. About 60 children in intensive …
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New registry tracks Real-World use of myriad™ in wound reconstruction
Knowledge-focused Recruiting nowThis observational study follows 800 adults who receive Myriad™ during soft tissue reconstruction for wounds like abdominal dehiscence, pressure injuries, or anal fistulas. Researchers track healing time, complications, and side effects to understand how well the material works i…
Sponsor: Aroa Biosurgery Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to unlock the mystery of strep carriers in kids
Knowledge-focused Recruiting nowThis study looks at children ages 5 to 15 who test positive for strep throat to understand why some become carriers—meaning they have the bacteria but no symptoms. Researchers will collect throat samples and analyze gene activity to compare carriers with those who have active inf…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Scientists hunt Tick-Borne germs to unlock disease patterns
Knowledge-focused Recruiting nowThis study is observing up to 2,000 people in Russia who have or may have rickettsiosis, a tick-borne illness. Researchers will collect leftover blood or swab samples from standard tests to identify the specific germ causing the infection. They will then compare the germ type wit…
Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Massive 10-Year study aims to map childhood infections in chinese ICUs
Knowledge-focused Recruiting nowThis study will collect data from 2,000 children admitted to pediatric intensive care units (PICUs) with severe infections across major Chinese cities. Over 10 years, researchers will track which germs cause these infections, how they are treated, and patient outcomes. The goal i…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study aims to perfect dosing of common staph infection drug
Knowledge-focused Recruiting nowThis study measures the amount of free cloxacillin in the blood of adults receiving the drug as a continuous infusion for severe staph infections. Researchers want to ensure levels are not too high or too low. They will use this data to create a model that predicts the right dose…
Phase: PHASE4 • Sponsor: Emeli Månsson • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Hidden kidney Super-Speed may undermine brain injury treatment
Knowledge-focused Recruiting nowThis study looks at a condition called augmented renal clearance (ARC), where the kidneys work too fast and flush out medications before they can help. It involves 512 adults in intensive care with severe brain injuries, strokes, seizures, or meningitis. Researchers will measure …
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Study tests how long a special blood filter fights sepsis toxins
Knowledge-focused Recruiting nowThis study looks at how well the Oxiris blood filter removes harmful toxins in adults with septic shock in the ICU. Researchers will take blood samples before and after the filter over 24 hours to see when it stops working. No new treatment is given—just observation. The goal is …
Sponsor: Pauls Stradins Clinical University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Which antibiotic combo is kinder to kidneys? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at two common antibiotic combinations given to hospitalized adults with infections: vancomycin plus piperacillin-tazobactam, or vancomycin plus cefepime. The goal is to see if one is less likely to cause kidney injury than the other, using more sensitive markers …
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Which fluid gauge saves more lives? new trial compares heart monitor vs. vein scan in sepsis
Knowledge-focused Recruiting nowThis study looks at 60 people with septic shock, a severe infection that causes dangerously low blood pressure. Doctors need to give fluids carefully, but too much can be harmful. The trial compares two methods—a heart monitor (cardiometry) and an ultrasound of a large vein (IVC …
Sponsor: Menoufia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Blood test may predict sepsis danger
Knowledge-focused Recruiting nowThis study aims to find epigenetic markers in the blood that could predict whether a patient with sepsis will develop the more dangerous septic shock. Researchers will take blood samples from 25 male patients after major digestive cancer surgery who develop sepsis. By comparing m…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
5,000 patients join Yale's quest to crack rheumatic disease mysteries
Knowledge-focused Recruiting nowThis study is building a large registry and biorepository of 5,000 adults with various rheumatic diseases like rheumatoid arthritis, lupus, and scleroderma. Researchers at Yale University will collect medical data and biological samples over time to better understand these condit…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Fast PCR test could speed up right antibiotic choice for blood infections
Knowledge-focused Recruiting nowThis study tests a rapid PCR test that identifies bacteria and drug resistance in about an hour, compared to standard methods that take 1-3 days. 300 adults with bloodstream infections will be randomly assigned to get either the rapid test plus standard care or standard care alon…
Sponsor: Istanbul Medipol University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Gut germs may worsen illness in ICU patients
Knowledge-focused Recruiting nowThis study looks at stool samples from 100 critically ill patients to understand how a common bacteria, Pseudomonas aeruginosa, becomes dangerous in the gut. Researchers will test if the gut environment makes the bacteria more harmful. No treatment is given; the goal is to learn …
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Could sepsis prematurely age your immune system?
Knowledge-focused Recruiting nowThis observational study looks at whether certain genetic elements, called transposable elements, can prematurely age the immune system in people with sepsis. Researchers will analyze blood samples from 116 ICU patients with sepsis to see if these elements are linked to higher de…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
C. diff showdown: antibiotics vs. poop pills – which works better?
Knowledge-focused Recruiting nowThis study watches 200 adults with C. diff infection to see how standard antibiotics and fecal microbiota transplantation (FMT) help people recover. Researchers will collect stool, blood, and urine samples over up to 5 years to understand why some treatments succeed and others fa…
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could shorter antibiotic courses be safer for blood cancer patients?
Knowledge-focused Recruiting nowThis study looks at whether blood cancer patients with a serious infection can safely stop antibiotics sooner if they are stable for 72 hours, instead of the usual 10-day course. About 172 adults will be randomly assigned to either a personalized short course or standard long cou…
Phase: NA • Sponsor: Humanitas University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Your home water may hide a lung infection risk for cystic fibrosis patients
Knowledge-focused Recruiting nowThis study is investigating whether germs called non-tuberculous mycobacteria (NTM) found in home water systems and dust can cause lung infections in people with cystic fibrosis. Researchers will collect samples from the homes of 120 CF patients—some with NTM infections and some …
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Big data study aims to sharpen chlamydia tracking for future vaccine
Knowledge-focused Recruiting nowThis study looks at over 500,000 patient records to see if diagnostic codes in electronic health records accurately identify chlamydia infections. Researchers will compare these codes with lab test results. The goal is to improve how real-world data is used for chlamydia research…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
TB survivors enroll in study to predict recurrence
Knowledge-focused Recruiting nowThis study looks at 750 people who have finished treatment for drug-sensitive tuberculosis. Researchers will test new sputum and blood-based methods to see if they can predict whether the disease will come back within a year. The goal is to find better ways to measure treatment s…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Cholesterol drug could boost TB treatment – new study tests best dose
Knowledge-focused Recruiting nowThis study looks at how the cholesterol-lowering drug atorvastatin behaves in the body when taken alongside standard tuberculosis (TB) medicines. Researchers will measure drug levels in 80 adults with pulmonary TB to find the best dose of atorvastatin that could help treat TB mor…
Phase: PHASE2 • Sponsor: Obafemi Awolowo University Teaching Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New registry aims to track brain infection outcomes
Knowledge-focused Recruiting nowThis study is a registry that collects information from 520 patients diagnosed with central nervous system (CNS) infections, such as meningitis or encephalitis. Researchers will track how many patients survive to discharge. The goal is to better understand these rare but serious …
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New study aims to predict who will survive Flesh-Eating infections
Knowledge-focused Recruiting nowThis study looks at 300 adults hospitalized with rare but life-threatening flesh-eating infections (necrotizing soft tissue infections). Researchers want to find out which early signs and routine lab tests can predict who is most likely to die during their hospital stay. The goal…
Sponsor: University of Cagliari • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
AI may help save painful teeth without root canal
Knowledge-focused Recruiting nowThis study tests whether artificial intelligence can predict if a less invasive procedure called full pulpotomy (removing only the infected pulp) will succeed in treating painful molars, compared to standard root canal treatment. Researchers will enroll 58 adults with irreversibl…
Phase: NA • Sponsor: Misr International University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
4,000 patients join landmark poop transplant safety study
Knowledge-focused Recruiting nowThis study is a national registry that will follow up to 4,000 people who receive a fecal microbiota transplant (FMT) for C. diff infection or other gut conditions. Researchers will track side effects, infections, and whether the disease comes back. The goal is to better understa…
Sponsor: American Gastroenterological Association • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
10,000 people tested: Cambodia's massive disease hunt begins
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for 57 different infectious diseases, including dengue, flu, and malaria. Researchers want to understand how these diseases spread and who is at risk. The goal is to give local health authorities the information they need to create b…
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC